No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2ds0A, 1.0000, 0.00, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH 6 -SIALYLLACTOSE
2, 2dryA, 0.9976, 0.21, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT
3, 2drzA, 0.9975, 0.21, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH LACTOSE
4, 2ds0B, 0.9856, 0.54, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH 6 -SIALYLLACTOSE
5, 2dryB, 0.9785, 0.67, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT
6, 2drzB, 0.9779, 0.67, 1.000, 130, 130, CRYSTAL STRUCTURE OF THE EARTHWORM LECTIN C-TERMINAL DOMAIN MUTANT IN COMPLEX WITH LACTOSE
7, 2zqoB, 0.9530, 1.15, 0.937, 130, 128, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH GALNAC
8, 2zqoA, 0.9525, 1.40, 0.930, 130, 129, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH GALNAC
9, 2zqnA, 0.9512, 1.20, 0.937, 131, 128, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH LACTOSE
10, 2zqnB, 0.9469, 1.50, 0.946, 131, 129, CRYSTAL STRUCTURE OF THE EARTHWORM R-TYPE LECTIN C-HALF IN COMPLEX WITH LACTOSE
11, 2rstA, 0.8925, 1.96, 0.953, 132, 129, NMR STRUCTURE OF THE C-TERMINAL DOMAIN OF EW29
12, 3vszB, 0.8475, 2.02, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
13, 3vsfB, 0.8475, 2.02, 0.185, 461, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
14, 3vt0B, 0.8474, 2.03, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
15, 3vt2F, 0.8473, 2.03, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
16, 3vt1B, 0.8473, 2.02, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
17, 3vsfF, 0.8468, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
18, 3vt0F, 0.8465, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
19, 3vszC, 0.8464, 2.04, 0.185, 482, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
20, 3vsfA, 0.8463, 2.03, 0.185, 461, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
21, 3vszA, 0.8462, 2.02, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
22, 3vt0A, 0.8458, 2.03, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
23, 3vszF, 0.8458, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
24, 3vsfC, 0.8456, 2.05, 0.185, 482, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
25, 3vt2C, 0.8454, 2.04, 0.185, 482, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
26, 3vt0C, 0.8450, 2.05, 0.185, 482, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
27, 3vt1F, 0.8449, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
28, 3vt1A, 0.8447, 2.03, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
29, 3vt2B, 0.8446, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
30, 3vt1C, 0.8445, 2.05, 0.185, 482, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
31, 3vszE, 0.8443, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
32, 3vsfE, 0.8441, 2.05, 0.185, 461, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
33, 3vt0E, 0.8439, 2.05, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
34, 3vt1E, 0.8438, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
35, 3vt2A, 0.8435, 2.04, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
36, 3vt2E, 0.8429, 2.05, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
37, 3pg0A, 0.8401, 2.14, 0.153, 140, 124, CRYSTAL STRUCTURE OF DESIGNED 3-FOLD SYMMETRIC PROTEIN THREEFOIL
38, 3vszD, 0.8356, 2.06, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTAN
39, 3vt0D, 0.8353, 2.06, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH LACTOSE
40, 3vsfD, 0.8348, 2.06, 0.185, 461, 124, CRYSTAL STRUCTURE OF 13GAL43A AN EXO-BETA-13-GALACTANASE FROM CLOSTRIDIUM THERMOCELLUM
41, 2x2sC, 0.8328, 2.63, 0.164, 148, 128, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
42, 2x2tA, 0.8245, 2.69, 0.164, 152, 128, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA IN COMPLEX WITH GAL-BETA13-GALNAC
43, 3vt1D, 0.8237, 2.14, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH GALACTOSE
44, 2x2sD, 0.8231, 2.68, 0.164, 152, 128, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
45, 3vt2D, 0.8220, 2.19, 0.185, 461, 124, CRYSTAL STRUCTURE OF CT13GAL43A IN COMPLEX WITH ISOPROPY-BETA-D- THIOGALACTOSIDE
46, 2x2sB, 0.8209, 2.72, 0.164, 152, 128, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
47, 2x2sA, 0.8191, 2.79, 0.164, 150, 128, CRYSTAL STRUCTURE OF SCLEROTINIA  SCLEROTIORUM  AGGLUTININ SSA
48, 1rzoB, 0.8184, 2.23, 0.195, 262, 123, AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA
49, 2vlcA, 0.8176, 2.17, 0.187, 518, 123, CRYSTAL STRUCTURE OF NATURAL CINNAMOMIN (ISOFORM III)
50, 2vlcB, 0.8175, 2.17, 0.187, 518, 123, CRYSTAL STRUCTURE OF NATURAL CINNAMOMIN (ISOFORM III)
51, 2aaiB, 0.8170, 2.27, 0.171, 262, 123, CRYSTALLOGRAPHIC REFINEMENT OF RICIN TO 2.5 ANGSTROMS
52, 3rtiB, 0.8159, 2.26, 0.171, 259, 123, CRYSTAL STRUCTURE OF RICIN BOUND WITH FORMYCIN MONOPHOSPHATE
53, 3rtjB, 0.8156, 2.26, 0.171, 262, 123, CRYSTAL STRUCTURE OF RICIN BOUND WITH DINUCLEOTIDE APG
54, 5d61A, 0.8151, 2.49, 0.157, 292, 127, MOA-Z-VAD-FMK COMPLEX DIRECT ORIENTATION
55, 5d62A, 0.8147, 2.49, 0.157, 292, 127, MOA-Z-VAD-FMK COMPLEX INVERTED ORIENTATION
56, 5mu9A, 0.8146, 2.50, 0.157, 292, 127, MOA-E-64 COMPLEX
57, 5d63A, 0.8145, 2.50, 0.157, 292, 127, MOA-Z-VAD-FMK INHIBITOR COMPLEX DIRECT/INVERTED DUAL ORIENTATION
58, 3ef2A, 0.8137, 2.50, 0.157, 291, 127, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
59, 3ef2B, 0.8136, 2.50, 0.157, 291, 127, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
60, 2zr1B, 0.8134, 2.22, 0.195, 263, 123, AGGLUTININ FROM ABRUS PRECATORIUS
61, 3ef2D, 0.8133, 2.50, 0.157, 291, 127, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
62, 3ef2C, 0.8130, 2.50, 0.157, 291, 127, STRUCTURE OF THE MARASMIUS OREADES MUSHROOM LECTIN (MOA) IN COMPLEX WITH GALALPHA(13)[FUCALPHA(12)]GAL AND CALCIUM.
63, 2zr1D, 0.8129, 2.22, 0.195, 263, 123, AGGLUTININ FROM ABRUS PRECATORIUS
64, 2q3nB, 0.8127, 2.21, 0.195, 261, 123, AGGLUTININ FROM ABRUS PRECATORIUS (APA-I)
65, 1rzoD, 0.8118, 2.28, 0.195, 262, 123, AGGLUTININ FROM RICINUS COMMUNIS WITH GALACTOAZA
66, 1abrB, 0.8118, 2.24, 0.179, 267, 123, CRYSTAL STRUCTURE OF ABRIN-A
67, 2mllB, 0.8111, 2.30, 0.187, 255, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM
68, 1ce7B, 0.8111, 2.30, 0.187, 255, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM
69, 1pc8B, 0.8110, 2.25, 0.187, 255, 123, CRYSTAL STRUCTURE OF A NOVEL FORM OF MISTLETOE LECTIN FROM HIMALAYAN VISCUM ALBUM L. AT 3.8A RESOLUTION
70, 4jkxB, 0.8105, 2.29, 0.187, 263, 123, CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH KINETIN AT 2.35 A RESOLUTION.
71, 3a22B, 0.8101, 2.18, 0.165, 612, 121, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH L- ARABINOSE
72, 2ihoA, 0.8101, 2.53, 0.157, 292, 127, CRYSTAL STRUCTURE OF MOA A LECTIN FROM THE MUSHROOM MARASMIUS OREADES IN COMPLEX WITH THE TRISACCHARIDE GAL(13)GAL(14)GLCNAC
73, 1isyB, 0.8101, 2.25, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GLUCOSE
74, 6elyB, 0.8097, 2.29, 0.187, 263, 123, CRYSTAL STRUCTURE OF MISTLETOE LECTIN I (ML-I) FROM VISCUM ALBUM IN COMPLEX WITH 4-N-FURFURYLCYTOSINE AT 2.84 A RESOLUTION 
75, 2r9kB, 0.8096, 2.29, 0.187, 262, 123, CRYSTAL STRUCTURE OF MISTELTOE LECTIN I IN COMPLEX WITH PHLORETAMIDE
76, 3o5wB, 0.8095, 2.28, 0.187, 262, 123, BINDING OF KINETIN IN THE ACTIVE SITE OF MISTLETOE LECTIN I
77, 4eb2B, 0.8094, 2.30, 0.187, 263, 123, CRYSTAL STRUCTURE MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE AT 1.94 A RESOLUTION.
78, 1m2tB, 0.8092, 2.30, 0.187, 262, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM IN COMPLEX WITH ADENINE MONOPHOSPHATE. CRYSTAL STRUCTURE AT 1.9 A RESOLUTION
79, 3d7wB, 0.8090, 2.30, 0.187, 262, 123, MISTLETOE LECTIN I IN COMPLEX WITH ZEATIN
80, 3a23B, 0.8090, 2.19, 0.165, 612, 121, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH D- GALACTOSE
81, 1onkB, 0.8090, 2.30, 0.179, 263, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM
82, 1v6uB, 0.8089, 2.26, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L- ARABINOFURANOSYL-XYLOBIOSE
83, 1oqlB, 0.8087, 2.30, 0.187, 263, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM COMPLEXED WITH GALACTOSE
84, 1v6wB, 0.8086, 2.26, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOBIOSE
85, 1pumB, 0.8086, 2.30, 0.187, 263, 123, MISTLETOE LECTIN I IN COMPLEX WITH GALACTOSE
86, 3c9zA, 0.8085, 2.18, 0.165, 257, 121, SAMBUCUS NIGRA AGGLUTININ II (SNA-II) TETRAGONAL CRYSTAL FORM
87, 2rg9B, 0.8085, 2.31, 0.187, 263, 123, CRYSTAL STRUCTURE OF VISCUM ALBUM MISTLETOE LECTIN I IN NATIVE STATE AT 1.95 A RESOLUTION COMPARISON OF STRUCTURE ACTIVE SITE CONFORMATION IN RICIN AND IN VISCUMIN
88, 2vsaA, 0.8082, 2.08, 0.148, 822, 122, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
89, 1sz6B, 0.8082, 2.31, 0.187, 263, 123, MISTLETOE LECTIN I FROM VISCUM ALBUM. CRYSTAL STRUCTURE AT 2.05 A RESOLUTION
90, 1puuB, 0.8082, 2.31, 0.187, 263, 123, MISTLETOE LECTIN I IN COMPLEX WITH LACTOSE
91, 1tfmB, 0.8081, 2.31, 0.179, 255, 123, CRYSTAL STRUCTURE OF A RIBOSOME INACTIVATING PROTEIN IN ITS NATURALLY INHIBITED FORM
92, 5y42F, 0.8079, 2.19, 0.197, 264, 122, NATIVE-CRYSTAL STRUCTURE OF THREE CHAIN NON-TOXIC TYPE II RIBOSOME INACTIVATING PROTEIN PURIFIED FROM THE SEEDS OF TRICHOSANTHES ANGUINA 
93, 1v6xB, 0.8078, 2.25, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(3)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOTRIOSE
94, 1iswA, 0.8077, 2.28, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOBIOSE
95, 3ca4A, 0.8076, 2.17, 0.165, 257, 121, SAMBUCUS NIGRA AGGLUTININ II TETRAGONAL CRYSTAL FORM- COMPLEXED TO LACTOSE
96, 2vseA, 0.8076, 2.26, 0.146, 823, 123, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
97, 3cahA, 0.8075, 2.17, 0.165, 257, 121, SAMBUCUS NIGRA AGGUTININ II. TETRAGONAL CRYSTAL FORM- COMPLEXED TO FUCOSE
98, 2vseB, 0.8075, 2.27, 0.146, 822, 123, STRUCTURE AND MODE OF ACTION OF A MOSQUITOCIDAL HOLOTOXIN
99, 1isvA, 0.8075, 2.28, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOSE
100, 1v6vB, 0.8073, 2.27, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L- ARABINOFURANOSYL-XYLOTRIOSE
101, 1hwmB, 0.8072, 1.85, 0.175, 264, 120, EBULINORTHORHOMBIC CRYSTAL FORM MODEL
102, 3ca3A, 0.8070, 2.18, 0.165, 257, 121, CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO N-ACETYLGALACTOSAMINE
103, 1knmA, 0.8066, 2.20, 0.190, 129, 121, STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH LACTOSE
104, 1v6vA, 0.8065, 2.26, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(2)-ALPHA-L- ARABINOFURANOSYL-XYLOTRIOSE
105, 1isxA, 0.8065, 2.28, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOTRIOSE
106, 4hr6C, 0.8064, 2.20, 0.197, 264, 122, CRYSTAL STRUCTURE OF SNAKE GOURD (TRICHOSANTHES ANGUINA) SEED LECTIN A THREE CHAIN HOMOLOGUE OF TYPE II RIPS
107, 3ca1A, 0.8063, 2.18, 0.165, 257, 121, SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO GALACTOSE
108, 3ca0A, 0.8063, 2.19, 0.165, 257, 121, SAMBUCUS NIGRA AGGLUTININ II (SNA-II) HEXAGONAL CRYSTAL FORM
109, 1v6wA, 0.8063, 2.29, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOBIOSE
110, 1isxB, 0.8063, 2.25, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOTRIOSE
111, 1iswB, 0.8062, 2.30, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOBIOSE
112, 1isvB, 0.8061, 2.27, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH XYLOSE
113, 1v6xA, 0.8060, 2.29, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 3(3)-4-O-METHYL-ALPHA- D-GLUCURONOSYL-XYLOTRIOSE
114, 1yf8B, 0.8058, 2.33, 0.179, 255, 123, CRYSTAL STRUCTURE OF HIMALAYAN MISTLETOE RIP REVEALS THE PRESENCE OF A NATURAL INHIBITOR AND A NEW FUNCTIONALLY ACTIVE SUGAR-BINDING SITE
115, 3ca6A, 0.8055, 2.19, 0.165, 257, 121, SAMBUCUS NIGRA AGGLUTININ II (SNA-II)- TETRAGONAL CRYSTAL FORM- COMPLEXED TO TN ANTIGEN
116, 3ca5A, 0.8055, 2.18, 0.165, 257, 121, CRYSTAL STRUCTURE OF SAMBUCUS NIGRA AGGLUTININ II (SNA-II)-TETRAGONAL CRYSTAL FORM- COMPLEXED TO ALPHA1 METHYLGALACTOSE
117, 3a21B, 0.8054, 2.20, 0.165, 612, 121, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS BETA-L- ARABINOPYRANOSIDASE
118, 3a23A, 0.8053, 2.23, 0.165, 614, 121, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH D- GALACTOSE
119, 3a22A, 0.8052, 2.22, 0.165, 614, 121, CRYSTAL STRUCTURE OF BETA-L-ARABINOPYRANOSIDASE COMPLEXED WITH L- ARABINOSE
120, 5y42C, 0.8050, 2.23, 0.197, 264, 122, NATIVE-CRYSTAL STRUCTURE OF THREE CHAIN NON-TOXIC TYPE II RIBOSOME INACTIVATING PROTEIN PURIFIED FROM THE SEEDS OF TRICHOSANTHES ANGUINA 
121, 5gqeA, 0.8050, 2.19, 0.192, 429, 120, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
122, 3a21A, 0.8047, 2.23, 0.165, 614, 121, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS BETA-L- ARABINOPYRANOSIDASE
123, 4lo7F, 0.8046, 2.33, 0.187, 286, 123, HA70(D3)-HA17-HA33
124, 4lo7B, 0.8046, 2.33, 0.187, 286, 123, HA70(D3)-HA17-HA33
125, 4lo0A, 0.8046, 2.33, 0.187, 286, 123, APO HA17-HA33
126, 4lo2A, 0.8044, 2.33, 0.187, 286, 123, HA17-HA33-LAC
127, 4qd2I, 0.8043, 2.33, 0.179, 286, 123, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
128, 4g9mA, 0.8040, 2.23, 0.165, 142, 121, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ
129, 4lo3A, 0.8039, 2.34, 0.187, 286, 123, HA17-HA33-LACNAC
130, 1v6uA, 0.8037, 2.33, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH 2(2)-ALPHA-L- ARABINOFURANOSYL-XYLOBIOSE
131, 1hwnB, 0.8037, 2.20, 0.174, 263, 121, EBULIN COMPLEXED WITH GALACTOSE TRIGONAL CRYSTAL FORM
132, 1hwoB, 0.8036, 2.28, 0.164, 263, 122, EBULIN COMPLEXED WITH LACTOSE TRIGONAL CRYSTAL FORM
133, 4lo1B, 0.8035, 2.33, 0.187, 285, 123, HA17-HA33-GAL
134, 1isyA, 0.8035, 2.32, 0.190, 436, 121, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GLUCOSE
135, 3aj5B, 0.8033, 2.24, 0.207, 283, 121, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
136, 3ah2A, 0.8033, 2.22, 0.207, 283, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
137, 1qxmA, 0.8029, 2.21, 0.207, 283, 121, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
138, 1hwpB, 0.8029, 2.27, 0.164, 263, 122, EBULIN COMPLEXED WITH PTEROIC ACID TRIGONAL CRYSTAL FORM
139, 4lo2B, 0.8027, 2.32, 0.187, 286, 123, HA17-HA33-LAC
140, 3aj6B, 0.8027, 2.03, 0.200, 284, 120, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
141, 3ah4A, 0.8027, 2.21, 0.207, 283, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
142, 3ah4B, 0.8025, 2.23, 0.207, 285, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH GALACTOSE
143, 2e4mB, 0.8025, 2.24, 0.207, 285, 121, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
144, 3ah1A, 0.8024, 2.23, 0.207, 283, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
145, 1ybiA, 0.8024, 2.36, 0.187, 284, 123, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
146, 4qd2H, 0.8023, 2.35, 0.187, 286, 123, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
147, 3ah1B, 0.8023, 2.24, 0.207, 288, 121, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLNEURAMIC ACID
148, 5gqeB, 0.8022, 2.19, 0.192, 429, 120, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
149, 4oujA, 0.8019, 2.39, 0.203, 281, 123, CRYSTAL STRUCTURE OF HA33B-LAC
150, 4g9nA, 0.8018, 2.25, 0.165, 142, 121, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ IN COMPLEX WITH N -ACETYL-GALACTOSAMINE
151, 3aj5A, 0.8018, 2.23, 0.207, 283, 121, HA1 (HA33) SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
152, 1qxmB, 0.8018, 2.24, 0.207, 283, 121, CRYSTAL STRUCTURE OF A HEMAGGLUTININ COMPONENT (HA1) FROM TYPE C CLOSTRIDIUM BOTULINUM
153, 4g9mB, 0.8017, 2.26, 0.165, 143, 121, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ
154, 3aj6A, 0.8016, 2.23, 0.207, 283, 121, HA1 (HA33) MUTANT F179I OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE BOUND AT SITE II
155, 4oujB, 0.8015, 2.39, 0.203, 281, 123, CRYSTAL STRUCTURE OF HA33B-LAC
156, 1knlA, 0.8014, 2.22, 0.183, 126, 120, STREPTOMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13
157, 5vbkB, 0.8009, 2.05, 0.134, 150, 119, CRYSTAL STRUCTURE OF A GALACTOSE-BINDING LECTIN FROM MYTILUS CALIFORNIANUS
158, 3nbeB, 0.8007, 2.31, 0.180, 147, 122, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
159, 4qd2C, 0.8000, 2.37, 0.187, 286, 123, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
160, 2e4mA, 0.7999, 2.25, 0.207, 285, 121, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
161, 1mc9A, 0.7994, 2.25, 0.183, 126, 120, STREPROMYCES LIVIDANS XYLAN BINDING DOMAIN CBM13 IN COMPLEX WITH XYLOPENTAOSE
162, 4g9nB, 0.7993, 2.28, 0.165, 143, 121, CRYSTAL STRUCTURE OF THE RHIZOCTONIA SOLANI AGGLUTININ IN COMPLEX WITH N -ACETYL-GALACTOSAMINE
163, 5bquA, 0.7992, 2.38, 0.187, 285, 123, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
164, 5f90A, 0.7972, 2.08, 0.143, 150, 119, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GB3 ALLYL
165, 5b2hA, 0.7970, 2.29, 0.207, 283, 121, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
166, 3nbeA, 0.7970, 2.33, 0.180, 147, 122, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH NN - DIACETYLLACTOSEDIAMINE
167, 5duyC, 0.7966, 2.08, 0.134, 150, 119, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
168, 3wmvA, 0.7960, 2.10, 0.134, 150, 119, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC WITH LIGAND FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
169, 5gqdA, 0.7958, 2.16, 0.195, 427, 118, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E- 86
170, 1it0A, 0.7958, 2.16, 0.195, 427, 118, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH LACTOSE
171, 5duyE, 0.7957, 2.09, 0.143, 150, 119, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
172, 5duyA, 0.7954, 2.09, 0.134, 150, 119, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
173, 5duyB, 0.7952, 2.09, 0.134, 150, 119, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
174, 3wmuA, 0.7947, 2.10, 0.134, 151, 119, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC APO-FORM FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
175, 5xg5A, 0.7946, 2.18, 0.100, 145, 120, CRYSTAL STRUCTURE OF MITSUBA-1 WITH BOUND NACGAL
176, 2d22A, 0.7944, 2.17, 0.195, 427, 118, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
177, 1xyfA, 0.7944, 2.18, 0.195, 427, 118, ENDO-14-BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS
178, 1iszA, 0.7942, 2.17, 0.195, 427, 118, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GALACTOSE
179, 5duyF, 0.7941, 2.11, 0.134, 150, 119, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
180, 5b2hB, 0.7940, 2.31, 0.207, 283, 121, CRYSTAL STRUCTURE OF HA33 FROM CLOSTRIDIUM BOTULINUM SEROTYPE C STRAIN YOICHI
181, 5gqdB, 0.7937, 2.18, 0.195, 427, 118, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF XYLANASE MUTANT (T82A N127S AND E128H) FROM STREPTOMYCES OLIVACEOVIRIDIS E- 86
182, 3wmuB, 0.7937, 2.13, 0.134, 153, 119, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC APO-FORM FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
183, 2d24B, 0.7936, 2.18, 0.195, 427, 118, CRYSTAL STRUCTURE OF ES COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
184, 2d20A, 0.7936, 2.17, 0.195, 427, 118, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
185, 3wmvB, 0.7933, 2.06, 0.136, 149, 118, THE STRUCTURE OF AN ANTI-CANCER LECTIN MYTILEC WITH LIGAND FROM THE MUSSEL MYTILUS GALLOPROVINCIALIS
186, 1iszB, 0.7931, 2.19, 0.195, 427, 118, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH GALACTOSE
187, 1xyfB, 0.7929, 2.19, 0.195, 427, 118, ENDO-14-BETA-XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS
188, 2d24A, 0.7928, 2.19, 0.195, 427, 118, CRYSTAL STRUCTURE OF ES COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
189, 5vbkA, 0.7926, 2.10, 0.134, 150, 119, CRYSTAL STRUCTURE OF A GALACTOSE-BINDING LECTIN FROM MYTILUS CALIFORNIANUS
190, 4owlE, 0.7926, 2.19, 0.149, 132, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
191, 2d1zA, 0.7926, 2.18, 0.195, 427, 118, CRYSTAL STRUCTURE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
192, 5f8yB, 0.7922, 2.06, 0.144, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSAMINE
193, 4owjB, 0.7922, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
194, 1it0B, 0.7922, 2.20, 0.195, 427, 118, CRYSTAL STRUCTURE OF XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86 COMPLEXED WITH LACTOSE
195, 4owlC, 0.7920, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
196, 4owkE, 0.7920, 2.20, 0.149, 136, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
197, 4owjG, 0.7920, 2.19, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
198, 4owkA, 0.7918, 2.18, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
199, 2d20B, 0.7918, 2.20, 0.195, 427, 118, CRYSTAL STRUCTURE OF MICHAELIS COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
200, 4owlD, 0.7917, 2.20, 0.149, 137, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
201, 4owjC, 0.7917, 2.19, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
202, 2d23A, 0.7917, 2.20, 0.195, 427, 118, CRYSTAL STRUCTURE OF EP COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
203, 5f8sB, 0.7916, 2.06, 0.136, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN
204, 4owkD, 0.7916, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
205, 4owjF, 0.7916, 2.20, 0.149, 132, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
206, 4owkF, 0.7915, 2.20, 0.149, 133, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
207, 5f8yA, 0.7914, 2.08, 0.144, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSAMINE
208, 5f8sA, 0.7914, 2.07, 0.144, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN
209, 2d22B, 0.7914, 2.20, 0.195, 427, 118, CRYSTAL STRUCTURE OF COVALENT GLYCOSYL-ENZYME INTERMEDIATE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
210, 5f90B, 0.7913, 2.07, 0.144, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GB3 ALLYL
211, 4owkG, 0.7912, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
212, 4jp0A, 0.7912, 2.29, 0.174, 378, 121, CRYSTAL STRUCTURE OF CRY35AB1
213, 5duyD, 0.7911, 2.07, 0.144, 149, 118, STRUCTURE OF LECTIN FROM THE SEA MUSSEL CRENOMYTILUS GRAYANUS
214, 4owlG, 0.7911, 2.22, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
215, 5f8wA, 0.7910, 2.08, 0.144, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSE
216, 3winA, 0.7910, 1.86, 0.161, 286, 118, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
217, 5f8wB, 0.7909, 2.08, 0.144, 149, 118, CRYSTAL STRUCTURE OF A CRENOMYTILUS GRAYANUS LECTIN IN COMPLEX WITH GALACTOSE
218, 2d1zB, 0.7907, 2.21, 0.195, 427, 118, CRYSTAL STRUCTURE OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
219, 4owlA, 0.7903, 2.21, 0.149, 132, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
220, 4owlF, 0.7901, 2.19, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
221, 4owjD, 0.7900, 2.20, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
222, 4owlB, 0.7899, 2.21, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-LACTOSAMINE BOUND
223, 2d23B, 0.7897, 2.21, 0.195, 427, 118, CRYSTAL STRUCTURE OF EP COMPLEX OF CATALYTIC-SITE MUTANT XYLANASE FROM STREPTOMYCES OLIVACEOVIRIDIS E-86
224, 4owkC, 0.7896, 2.22, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
225, 4iy9B, 0.7895, 2.28, 0.081, 235, 124, BMLP3 - C2 CRYSTAL FORM
226, 3winB, 0.7895, 2.48, 0.187, 286, 123, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
227, 4zgrB, 0.7893, 2.18, 0.210, 261, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH T-ANTIGEN.
228, 3nbdB, 0.7888, 2.37, 0.172, 148, 122, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
229, 4zfyB, 0.7884, 1.87, 0.188, 261, 117, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH ALPHA-METHYL-D- GALACTOSIDE
230, 1ggpB, 0.7878, 2.26, 0.183, 254, 120, CRYSTAL STRUCTURE OF TRICHOSANTHES KIRILOWII LECTIN-1 AND ITS RELATION TO THE TYPE 2 RIBOSOME INACTIVATING PROTEINS
231, 4zfwB, 0.7877, 2.19, 0.210, 261, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH GALACTOSE.
232, 4z8sB, 0.7876, 2.19, 0.210, 261, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-1
233, 4zbvB, 0.7875, 2.21, 0.210, 261, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH BENZYL T-ANTIGEN
234, 3nbdA, 0.7869, 2.38, 0.172, 148, 122, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 7.1
235, 5nqaB, 0.7867, 2.38, 0.152, 513, 125, CRYSTAL STRUCTURE OF GALNAC-T4 IN COMPLEX WITH THE MONOGLYCOPEPTIDE 3
236, 3ah2B, 0.7866, 1.78, 0.181, 283, 116, HA1 SUBCOMPONENT OF BOTULINUM TYPE C PROGENITOR TOXIN COMPLEXED WITH N-ACETYLGALACTOSAMINE
237, 4zfuB, 0.7865, 2.20, 0.210, 261, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH N-ACETYL D GALACTOSAMINE
238, 4iy8D, 0.7853, 2.36, 0.081, 239, 124, BMLP3 - P21 CRYSTAL FORM
239, 4z9wB, 0.7850, 2.25, 0.210, 261, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-2
240, 5nqaA, 0.7847, 2.41, 0.152, 514, 125, CRYSTAL STRUCTURE OF GALNAC-T4 IN COMPLEX WITH THE MONOGLYCOPEPTIDE 3
241, 4zlbB, 0.7846, 2.23, 0.210, 261, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD) IN COMPLEX WITH LACTOSE
242, 4iy8A, 0.7841, 2.41, 0.081, 239, 124, BMLP3 - P21 CRYSTAL FORM
243, 4za3B, 0.7834, 2.27, 0.210, 260, 119, STRUCTURAL STUDIES ON A NON-TOXIC HOMOLOGUE OF TYPE II RIPS FROM MOMORDICA CHARANTIA (BITTER GOURD)-NATIVE-3
244, 3nbcB, 0.7826, 2.41, 0.172, 148, 122, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
245, 3nbcA, 0.7825, 2.42, 0.172, 148, 122, CLITOCYBE NEBULARIS RICIN B-LIKE LECTIN (CNL) IN COMPLEX WITH LACTOSE CRYSTALLIZED AT PH 4.4
246, 4iy8C, 0.7824, 2.34, 0.081, 239, 124, BMLP3 - P21 CRYSTAL FORM
247, 4qd2D, 0.7820, 1.82, 0.164, 286, 116, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
248, 4owjE, 0.7818, 2.30, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
249, 4owjA, 0.7811, 2.29, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN
250, 3pubB, 0.7806, 2.34, 0.081, 236, 123, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
251, 5bp5B, 0.7805, 1.82, 0.172, 285, 116, CRYSTAL STRUCTURE OF HA17-HA33-IPT
252, 4iy8B, 0.7804, 2.44, 0.081, 239, 124, BMLP3 - P21 CRYSTAL FORM
253, 1ybiB, 0.7801, 1.82, 0.164, 284, 116, CRYSTAL STRUCTURE OF HA33A A NEUROTOXIN-ASSOCIATED PROTEIN FROM CLOSTRIDIUM BOTULINUM TYPE A
254, 5bquB, 0.7796, 1.83, 0.172, 277, 116, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
255, 4owkB, 0.7796, 2.33, 0.149, 131, 121, CRYSTAL STRUCTURE OF THE VIBRIO VULNIFICUS HEMOLYSIN/CYTOLYSIN BETA- TREFOIL LECTIN WITH N-ACETYL-D-GALACTOSAMINE BOUND
256, 4lo3B, 0.7795, 1.84, 0.172, 285, 116, HA17-HA33-LACNAC
257, 3pubA, 0.7795, 2.46, 0.073, 235, 124, CRYSTAL STRUCTURE OF THE BOMBYX MORI LOW MOLECULAR WEIGHT LIPOPROTEIN 7 (BMLP7)
258, 4lo7H, 0.7794, 1.84, 0.172, 286, 116, HA70(D3)-HA17-HA33
259, 4lo7D, 0.7794, 1.84, 0.172, 286, 116, HA70(D3)-HA17-HA33
260, 4lo0B, 0.7794, 1.84, 0.172, 285, 116, APO HA17-HA33
261, 4lo1A, 0.7787, 1.85, 0.172, 286, 116, HA17-HA33-GAL
262, 3phzB, 0.7785, 2.31, 0.143, 278, 119, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
263, 4iy9A, 0.7784, 2.44, 0.081, 235, 124, BMLP3 - C2 CRYSTAL FORM
264, 5bp5A, 0.7783, 1.86, 0.172, 286, 116, CRYSTAL STRUCTURE OF HA17-HA33-IPT
265, 4pc4C, 0.7778, 2.49, 0.097, 240, 124, BOMBYX MORI LIPOPROTEIN 6
266, 4pc4A, 0.7778, 2.50, 0.097, 238, 124, BOMBYX MORI LIPOPROTEIN 6
267, 4pc4D, 0.7777, 2.50, 0.097, 238, 124, BOMBYX MORI LIPOPROTEIN 6
268, 4pc4E, 0.7772, 2.52, 0.097, 239, 124, BOMBYX MORI LIPOPROTEIN 6
269, 3phzA, 0.7765, 2.29, 0.143, 278, 119, CRYSTAL STRUCTURE ANALYSIS OF POLYPORUS SQUAMOSUS LECTIN BOUND TO HUMAN-TYPE INFLUENZA-BINDING EPITOPE NEU5ACA2-6GALB1-4GLCNAC
270, 4pc4B, 0.7759, 2.50, 0.097, 238, 124, BOMBYX MORI LIPOPROTEIN 6
271, 5ehaA, 0.7752, 2.16, 0.133, 153, 120, CRYSTAL STRUCTURE OF RECOMBINANT MTAL AT 1.35 ANGSTROM RESOLUTION
272, 3w9tF, 0.7748, 2.17, 0.144, 431, 118, PORE-FORMING CEL-III
273, 3w9tD, 0.7748, 2.17, 0.144, 431, 118, PORE-FORMING CEL-III
274, 3w9tC, 0.7747, 2.17, 0.144, 431, 118, PORE-FORMING CEL-III
275, 3w9tA, 0.7747, 2.17, 0.144, 431, 118, PORE-FORMING CEL-III
276, 3w9tG, 0.7746, 2.17, 0.144, 431, 118, PORE-FORMING CEL-III
277, 3w9tB, 0.7746, 2.17, 0.144, 431, 118, PORE-FORMING CEL-III
278, 1upsA, 0.7746, 2.27, 0.100, 402, 120, GLCNAC[ALPHA]1-4GAL RELEASING ENDO-[BETA]-GALACTOSIDASE FROM CLOSTRIDIUM PERFRINGENS
279, 3w9tE, 0.7745, 2.17, 0.144, 431, 118, PORE-FORMING CEL-III
280, 2z49B, 0.7735, 2.22, 0.144, 431, 118, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
281, 5muaB, 0.7733, 2.38, 0.143, 275, 119, PSL1A-E64 COMPLEX
282, 2f2fA, 0.7733, 2.87, 0.095, 153, 126, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
283, 2f2fD, 0.7730, 2.87, 0.095, 153, 126, CRYSTAL STRUCTURE OF CYTOLETHAL DISTENDING TOXIN (CDT) FROM ACTINOBACILLUS ACTINOMYCETEMCOMITANS
284, 4efqA, 0.7727, 2.37, 0.074, 234, 122, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
285, 2z49A, 0.7724, 2.23, 0.144, 431, 118, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH METHYL-ALPHA-D-GALACTOPYLANOSIDE
286, 4efqB, 0.7723, 2.47, 0.065, 234, 123, BOMBYX MORI LIPOPROTEIN 7 - PLATINUM DERIVATIVE AT 1.94 A RESOLUTION
287, 1vclA, 0.7720, 2.24, 0.144, 431, 118, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
288, 1vclB, 0.7711, 2.25, 0.144, 431, 118, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III
289, 4efpA, 0.7709, 2.40, 0.074, 234, 122, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
290, 2ffuA, 0.7709, 2.01, 0.111, 494, 117, CRYSTAL STRUCTURE OF HUMAN PPGALNACT-2 COMPLEXED WITH UDP AND EA2
291, 4efrC, 0.7708, 2.38, 0.074, 235, 122, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
292, 1upsB, 0.7705, 2.26, 0.101, 397, 119, GLCNAC[ALPHA]1-4GAL RELEASING ENDO-[BETA]-GALACTOSIDASE FROM CLOSTRIDIUM PERFRINGENS
293, 4uspA, 0.7704, 2.11, 0.112, 135, 116, X-RAY STRUCTURE OF THE DIMERIC CCL2 LECTIN IN NATIVE FORM
294, 4efrA, 0.7704, 2.37, 0.074, 234, 122, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
295, 4izxA, 0.7703, 2.30, 0.171, 139, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH LACTOSE
296, 4iybB, 0.7702, 2.30, 0.171, 140, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
297, 4usoB, 0.7701, 2.12, 0.112, 135, 116, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
298, 4j2sA, 0.7700, 2.30, 0.171, 139, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH DI- LACNAC
299, 4efpB, 0.7700, 2.49, 0.065, 234, 123, BOMBYX MORI LIPOPROTEIN 7 ISOLATED FROM ITS NATURAL SOURCE AT 1.33 A RESOLUTION
300, 4uspB, 0.7699, 2.11, 0.112, 135, 116, X-RAY STRUCTURE OF THE DIMERIC CCL2 LECTIN IN NATIVE FORM
301, 4usoA, 0.7697, 2.13, 0.112, 136, 116, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
302, 2z48B, 0.7689, 2.26, 0.144, 431, 118, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
303, 2z48A, 0.7688, 2.26, 0.144, 431, 118, CRYSTAL STRUCTURE OF HEMOLYTIC LECTIN CEL-III COMPLEXED WITH GALNAC
304, 4ionB, 0.7687, 2.31, 0.171, 140, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
305, 5muaA, 0.7667, 2.03, 0.148, 269, 115, PSL1A-E64 COMPLEX
306, 4iybA, 0.7663, 2.36, 0.171, 140, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL) IN COMPLEX WITH GALACTOSE
307, 4efrB, 0.7662, 2.44, 0.074, 233, 122, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
308, 2y9wD, 0.7660, 2.33, 0.133, 135, 120, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
309, 4ionA, 0.7659, 2.36, 0.171, 140, 117, MACROLEPIOTA PROCERA RICIN B-LIKE LECTIN (MPL)
310, 5g37A, 0.7658, 2.55, 0.091, 364, 121, MR STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 5
311, 2y9wC, 0.7656, 2.35, 0.133, 136, 120, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT
312, 2d7rA, 0.7650, 2.80, 0.163, 536, 123, CRYSTAL STRUCTURE OF PP-GALNAC-T10 COMPLEXED WITH GALNAC-SER ON LECTIN DOMAIN
313, 4efrD, 0.7647, 2.43, 0.074, 233, 122, BOMBYX MORI LIPOPROTEIN 7 (CRYSTAL FORM II) AT 2.50 A RESOLUTION
314, 2d7iA, 0.7645, 2.80, 0.163, 536, 123, CRSYTAL STRUCTURE OF PP-GALNAC-T10 WITH UDP GALNAC AND MN2+
315, 5ajpA, 0.7638, 1.97, 0.103, 495, 116, CRYSTAL STRUCTURE OF THE ACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH UDP AND THE GLYCOPEPTIDE MUC5AC-13
316, 1sr4A, 0.7635, 2.98, 0.087, 167, 126, CRYSTAL STRUCTURE OF THE HAEMOPHILUS DUCREYI CYTOLETHAL DISTENDING TOXIN
317, 2y9xF, 0.7634, 2.34, 0.133, 136, 120, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
318, 5fv9F, 0.7631, 1.98, 0.103, 481, 116, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
319, 5fozA, 0.7631, 2.54, 0.083, 364, 121, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
320, 2y9xE, 0.7631, 2.36, 0.133, 136, 120, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
321, 5ajoA, 0.7628, 1.97, 0.103, 495, 116, CRYSTAL STRUCTURE OF THE INACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH THE GLYCOPEPTIDE MUC5AC-313
322, 1wd4A, 0.7628, 2.18, 0.085, 482, 118, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOSE
323, 4l4iA, 0.7627, 2.58, 0.065, 473, 124, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547 DISEASE MUTANT R420Q
324, 5foyA, 0.7623, 2.55, 0.083, 367, 121, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 7
325, 2d44A, 0.7623, 2.19, 0.085, 482, 118, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOFURANOSYL-ALPHA-12-XYLOBIOSE
326, 1wd3A, 0.7623, 2.18, 0.085, 482, 118, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE
327, 5fv9E, 0.7620, 2.19, 0.103, 483, 117, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
328, 6egsB, 0.7619, 2.00, 0.112, 467, 116, CRYSTAL STRUCTURE OF THE GALNAC-T2 F104S MUTANT IN COMPLEX WITH UDP- GALNAC 
329, 1jlxB, 0.7615, 2.76, 0.122, 299, 123, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
330, 2d43A, 0.7614, 2.19, 0.085, 482, 118, CRYSTAL STRUCTURE OF ARABINOFURANOSIDASE COMPLEXED WITH ARABINOTRIOSE
331, 5ajnA, 0.7613, 1.99, 0.103, 495, 116, CRYSTAL STRUCTURE OF THE INACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH THE GLYCOPEPTIDE MUC5AC-CYS13
332, 6egsA, 0.7612, 2.01, 0.112, 478, 116, CRYSTAL STRUCTURE OF THE GALNAC-T2 F104S MUTANT IN COMPLEX WITH UDP- GALNAC 
333, 1jlyB, 0.7612, 2.77, 0.122, 299, 123, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
334, 3a07B, 0.7611, 1.97, 0.186, 118, 113, CRYSTAL STRUCTURE OF ACTINOHIVIN; POTENT ANTI-HIV PROTEIN
335, 2y9xH, 0.7611, 2.37, 0.133, 136, 120, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
336, 3malB, 0.7608, 2.48, 0.066, 181, 121, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
337, 5fv9B, 0.7604, 2.00, 0.103, 484, 116, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
338, 3malA, 0.7604, 2.46, 0.066, 181, 121, CRYSTAL STRUCTURE OF THE SDF2-LIKE PROTEIN FROM ARABIDOPSIS THALIANA
339, 5ndfD, 0.7603, 2.00, 0.103, 495, 116, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
340, 4d0tB, 0.7602, 2.11, 0.111, 495, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
341, 4d0tA, 0.7600, 2.00, 0.103, 496, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
342, 4usoC, 0.7599, 2.15, 0.113, 130, 115, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
343, 3a07A, 0.7599, 1.97, 0.186, 116, 113, CRYSTAL STRUCTURE OF ACTINOHIVIN; POTENT ANTI-HIV PROTEIN
344, 2y9xG, 0.7599, 2.37, 0.133, 136, 120, CRYSTAL STRUCTURE OF PPO3 A TYROSINASE FROM AGARICUS BISPORUS IN DEOXY-FORM THAT CONTAINS ADDITIONAL UNKNOWN LECTIN-LIKE SUBUNIT WITH INHIBITOR TROPOLONE
345, 4d0zE, 0.7598, 2.01, 0.103, 495, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
346, 4d0zA, 0.7596, 2.01, 0.103, 495, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
347, 4g1rC, 0.7595, 1.82, 0.187, 114, 112, CRYSTAL STRUCTURE OF ANTI-HIV ACTINOHIVIN IN COMPLEX WITH ALPHS-12- MANNOBIOSE (FORM II)
348, 4a7zA, 0.7594, 2.77, 0.107, 881, 121, COMPLEX OF BIFUNCTIONAL ALDOS-2-ULOSE DEHYDRATASE WITH THE REACTION INTERMEDIATE ASCOPYRONE M
349, 5ndfB, 0.7593, 2.12, 0.111, 495, 117, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
350, 4d11D, 0.7591, 2.22, 0.103, 487, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
351, 4d0zD, 0.7591, 2.01, 0.103, 495, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
352, 5ndfA, 0.7590, 2.01, 0.103, 495, 116, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
353, 5fv9C, 0.7590, 2.31, 0.119, 482, 118, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
354, 1jlxA, 0.7589, 2.79, 0.122, 299, 123, AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
355, 4d0tD, 0.7588, 2.12, 0.111, 495, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
356, 4p6aA, 0.7585, 1.82, 0.187, 114, 112, CRYSTAL STRUCTURE OF A POTENT ANTI-HIV LECTIN ACTINOHIVIN IN COMPLEX WITH ALPHA-12-MANNOTRIOSE
357, 4d0tE, 0.7585, 2.02, 0.103, 495, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
358, 4d0zB, 0.7584, 2.13, 0.111, 495, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
359, 1jlyA, 0.7583, 2.79, 0.122, 299, 123, CRYSTAL STRUCTURE OF AMARANTHUS CAUDATUS AGGLUTININ
360, 4d11B, 0.7582, 2.23, 0.103, 482, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
361, 4g1rA, 0.7581, 1.83, 0.187, 114, 112, CRYSTAL STRUCTURE OF ANTI-HIV ACTINOHIVIN IN COMPLEX WITH ALPHS-12- MANNOBIOSE (FORM II)
362, 4d11E, 0.7580, 2.23, 0.103, 487, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
363, 4d0zF, 0.7579, 2.03, 0.103, 491, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
364, 1t9fA, 0.7579, 2.57, 0.066, 178, 122, STRUCTURAL GENOMICS OF CAENORHABDITIS ELEGANS: STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION
365, 4a7yA, 0.7578, 2.83, 0.107, 880, 121, ACTIVE SITE METAL DEPLETED ALDOS-2-ULOSE DEHYDRATASE
366, 4a7kA, 0.7578, 2.80, 0.107, 879, 121, BIFUNCTIONAL ALDOS-2-ULOSE DEHYDRATASE
367, 5fv9A, 0.7575, 2.03, 0.103, 483, 116, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
368, 4d11A, 0.7574, 2.03, 0.103, 491, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 PEPTIDE AND MANGANESE (LOWER RESOLUTION DATASET)
369, 1xhbA, 0.7574, 2.38, 0.132, 447, 121, THE CRYSTAL STRUCTURE OF UDP-GALNAC: POLYPEPTIDE ALPHA-N- ACETYLGALACTOSAMINYLTRANSFERASE-T1
370, 4d0tC, 0.7573, 2.14, 0.111, 495, 117, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
371, 5ndfF, 0.7572, 2.13, 0.111, 495, 117, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
372, 4uweD, 0.7572, 2.80, 0.065, 3322, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
373, 4uweC, 0.7572, 2.80, 0.065, 3322, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
374, 4uweB, 0.7572, 2.80, 0.065, 3322, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
375, 4uweA, 0.7572, 2.80, 0.065, 3322, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 8.5 A IN PARTIALLY OPEN STATE
376, 4uwaD, 0.7572, 2.80, 0.065, 3324, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
377, 4uwaC, 0.7572, 2.80, 0.065, 3324, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
378, 4uwaB, 0.7572, 2.80, 0.065, 3324, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
379, 4uwaA, 0.7572, 2.80, 0.065, 3324, 124, STRUCTURE OF THE RYANODINE RECEPTOR AT RESOLUTION OF 6.1 A IN CLOSED STATE
380, 5ndfC, 0.7569, 2.14, 0.111, 495, 117, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
381, 4d0zC, 0.7566, 2.04, 0.103, 476, 116, GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)
382, 4jkqA, 0.7559, 2.62, 0.066, 499, 122, CRYSTAL STRUCTURE OF THE N-TERMINAL REGION OF THE HUMAN RYANODINE RECEPTOR 2
383, 4endA, 0.7559, 1.86, 0.187, 114, 112, CRYSTAL STRUCTURE OF ANTI-HIV ACTINOHIVIN IN COMPLEX WITH ALPHA-12- MANNOBIOSE (P 2 21 21 FORM)
384, 3kmvE, 0.7556, 2.24, 0.095, 140, 116, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
385, 1fwvA, 0.7553, 2.36, 0.119, 134, 118, CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(A)
386, 1fwuA, 0.7550, 2.36, 0.119, 134, 118, CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(X)
387, 1dqoA, 0.7548, 2.36, 0.119, 134, 118, CRYSTAL STRUCTURE OF THE CYSTEINE RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH ACETYLGALACTOSAMINE-4-SULFATE
388, 1n4kA, 0.7542, 2.48, 0.091, 292, 121, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR BINDING CORE IN COMPLEX WITH IP3
389, 1dqgA, 0.7542, 2.37, 0.119, 134, 118, CRYSTAL STRUCTURE OF THE CYSTEINE RICH DOMAIN OF MANNOSE RECEPTOR
390, 4usoD, 0.7525, 2.03, 0.115, 130, 113, X-RAY STRUCTURE OF THE CCL2 LECTIN IN COMPLEX WITH SIALYL LEWIS X
391, 3kmvH, 0.7521, 2.18, 0.087, 139, 115, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
392, 5ndfE, 0.7516, 2.13, 0.112, 492, 116, SMALL-MOLECULE INHIBITION OF PPGALNAC-TS SELECTIVELY REDUCES MUCIN- TYPE O-GLYCOSYLATION
393, 3kmvG, 0.7508, 2.18, 0.087, 138, 115, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
394, 3kmvB, 0.7502, 2.18, 0.087, 138, 115, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
395, 3kmvD, 0.7500, 2.24, 0.078, 138, 115, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
396, 4qkrA, 0.7498, 2.07, 0.113, 125, 115, CRYSTAL STRUCTURE OF 6XTYR/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE (L22Y/L44Y/L64Y/L85Y/L108Y/L132Y PRIMITIVE VERSION 2)
397, 3q7wA, 0.7496, 2.02, 0.132, 124, 114, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 1
398, 1w3gA, 0.7485, 2.83, 0.131, 312, 122, HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH TWO N-ACETYLLACTOSAMINE MOLECULES.
399, 1w3fA, 0.7476, 2.82, 0.131, 312, 122, CRYSTAL STRUCTURE OF THE HEMOLYTIC LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS COMPLEXED WITH N-ACETYLLACTOSAMINE IN THE GAMMA MOTIF
400, 6dqjD, 0.7475, 2.82, 0.098, 2181, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
401, 6dqjC, 0.7475, 2.82, 0.098, 2181, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
402, 6dqjB, 0.7475, 2.82, 0.098, 2181, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
403, 6dqjA, 0.7475, 2.82, 0.098, 2181, 123, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
404, 4l4hA, 0.7474, 2.62, 0.066, 466, 122, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR ISOFORM 2 (RYR2) 1-547
405, 1xzzA, 0.7473, 2.45, 0.042, 216, 119, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 1 INOSITOL 145-TRISPHOSPHATE RECEPTOR
406, 1w3aA, 0.7470, 2.82, 0.131, 312, 122, THREE DIMENSIONAL STRUCTURE OF A NOVEL PORE-FORMING LECTIN FROM THE MUSHROOM LAETIPORUS SULPHUREUS
407, 3kmvF, 0.7468, 2.14, 0.079, 137, 114, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
408, 6dqnD, 0.7466, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
409, 6dqnC, 0.7466, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
410, 6dqnB, 0.7466, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
411, 6dqnA, 0.7466, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
412, 6dqzC, 0.7462, 2.77, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
413, 5y9vB, 0.7460, 2.28, 0.085, 170, 117, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
414, 6dqzD, 0.7458, 2.77, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
415, 6dr0D, 0.7456, 2.61, 0.091, 2181, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
416, 4f34C, 0.7456, 2.05, 0.114, 124, 114, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
417, 4qksA, 0.7455, 2.05, 0.123, 124, 114, CRYSTAL STRUCTURE OF 6XTRP/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE (L22W/L44W/L64W/L85W/L108W/L132W HIS PRIMITIVE VERSION 2)
418, 2liqA, 0.7451, 2.32, 0.112, 153, 116, SOLUTION STRUCTURE OF CCL2 IN COMPLEX WITH GLYCAN
419, 5gugA, 0.7449, 2.60, 0.091, 1721, 121, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
420, 3uj0A, 0.7449, 2.62, 0.091, 502, 121, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
421, 3uj0B, 0.7448, 2.62, 0.091, 502, 121, CRYSTAL STRUCTURE OF THE INOSITOL 145-TRISPHOSPHATE RECEPTOR WITH LIGAND BOUND FORM.
422, 3kmvC, 0.7447, 2.18, 0.079, 137, 114, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
423, 6dr0B, 0.7446, 2.62, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
424, 6dqzA, 0.7445, 2.63, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
425, 6dqvD, 0.7444, 2.63, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
426, 6dqvC, 0.7444, 2.63, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
427, 6dqvB, 0.7444, 2.63, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
428, 6dqvA, 0.7444, 2.63, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
429, 6dqzB, 0.7443, 2.63, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
430, 4qd2G, 0.7443, 2.50, 0.155, 143, 116, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
431, 6dr0A, 0.7440, 2.64, 0.091, 2188, 121, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
432, 4lo3C, 0.7439, 2.52, 0.172, 144, 116, HA17-HA33-LACNAC
433, 6dr2D, 0.7438, 2.71, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
434, 6dr2C, 0.7438, 2.71, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
435, 6dr2B, 0.7438, 2.71, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
436, 6dr2A, 0.7438, 2.71, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
437, 3o44N, 0.7437, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
438, 3o44G, 0.7436, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
439, 3o44D, 0.7436, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
440, 3o44A, 0.7436, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
441, 3akhA, 0.7436, 2.24, 0.043, 447, 115, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE COMPLEXED WITH ALPHA-15-L-ARABINOFURANOTRIOSE
442, 3o44E, 0.7435, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
443, 3o44B, 0.7435, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
444, 3o44K, 0.7434, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
445, 3o44I, 0.7434, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
446, 3o44L, 0.7433, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
447, 3o44H, 0.7433, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
448, 3o44F, 0.7433, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
449, 3o44C, 0.7433, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
450, 3im5B, 0.7433, 2.37, 0.085, 175, 118, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (RESIDUES 1-217)
451, 3o44M, 0.7432, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
452, 3o44J, 0.7432, 2.19, 0.122, 581, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) HEPTAMERIC PORE
453, 6drcD, 0.7431, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
454, 6drcC, 0.7431, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
455, 6drcA, 0.7431, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
456, 4lo2C, 0.7431, 2.52, 0.164, 144, 116, HA17-HA33-LAC
457, 6drcB, 0.7430, 2.76, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
458, 2y9fA, 0.7430, 2.65, 0.132, 149, 121, HIGH-RESOLUTION STRUCTURAL INSIGHTS ON THE SUGAR- RECOGNITION AND FUSION TAG PROPERTIES OF A VERSATILE B- TREFOIL LECTIN DOMAIN
459, 5bp5C, 0.7428, 2.52, 0.164, 144, 116, CRYSTAL STRUCTURE OF HA17-HA33-IPT
460, 4lo1C, 0.7428, 2.52, 0.164, 144, 116, HA17-HA33-GAL
461, 3q7xA, 0.7427, 2.04, 0.115, 124, 113, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 1
462, 3jrrA, 0.7427, 2.44, 0.042, 216, 119, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
463, 4qd2B, 0.7426, 2.51, 0.155, 143, 116, MOLECULAR BASIS FOR DISRUPTION OF E-CADHERIN ADHESION BY BOTULINUM NEUROTOXIN A COMPLEX
464, 4denA, 0.7426, 1.84, 0.191, 112, 110, STRUCTURAL INSIGHTSINTO POTENT SPECIFIC ANTI-HIV PROPERTY OF ACTINOHIVIN; CRYSTAL STRUCTURE OF ACTINOHIVIN IN COMPLEX WITH ALPHA(1-2) MANNOBIOSE MOIETY OF HIGH-MANNOSE TYPE GLYCAN OF GP120
465, 3jrrB, 0.7426, 2.44, 0.042, 219, 119, CRYSTAL STRUCTURE OF THE LIGAND BINDING SUPPRESSOR DOMAIN OF TYPE 3 INOSITOL 145-TRISPHOSPHATE RECEPTOR
466, 5bquC, 0.7425, 2.52, 0.164, 144, 116, CRYSTAL STRUCTURE OF HA17-HA33-LACTULOSE
467, 3t8sA, 0.7425, 2.70, 0.091, 501, 121, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
468, 4d8hA, 0.7424, 2.08, 0.105, 124, 114, CRYSTAL STRUCTURE OF SYMFOIL-4P/PV2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE PRIMITIVE VERSION 2 (6XLEU / PV1)
469, 4lo7G, 0.7423, 2.52, 0.164, 139, 116, HA70(D3)-HA17-HA33
470, 4lo7C, 0.7423, 2.52, 0.164, 139, 116, HA70(D3)-HA17-HA33
471, 4lo0C, 0.7423, 2.52, 0.164, 144, 116, APO HA17-HA33
472, 3akfA, 0.7423, 2.24, 0.043, 447, 115, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE
473, 1xezA, 0.7422, 2.17, 0.122, 663, 115, CRYSTAL STRUCTURE OF THE VIBRIO CHOLERAE CYTOLYSIN (HLYA) PRO-TOXIN WITH OCTYLGLUCOSIDE BOUND
474, 6dqsC, 0.7421, 2.78, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
475, 6dqsA, 0.7421, 2.77, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
476, 4lo8H, 0.7421, 2.51, 0.164, 143, 116, HA70(D3)-HA17
477, 6dr0C, 0.7419, 2.80, 0.090, 2193, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
478, 4lo8B, 0.7415, 2.52, 0.164, 143, 116, HA70(D3)-HA17
479, 3uj4B, 0.7414, 2.91, 0.089, 490, 123, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
480, 4lo8F, 0.7413, 2.54, 0.164, 142, 116, HA70(D3)-HA17
481, 3kmvA, 0.7411, 2.14, 0.080, 136, 113, CRYSTAL STRUCTURE OF CBM42A FROM CLOSTRIDIUM THERMOCELLUM
482, 6draD, 0.7410, 2.73, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
483, 6draC, 0.7410, 2.73, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
484, 6draB, 0.7410, 2.73, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
485, 6draA, 0.7410, 2.73, 0.090, 2191, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
486, 6dqsB, 0.7403, 2.80, 0.090, 2186, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
487, 3q7yA, 0.7398, 2.07, 0.115, 124, 113, CRYSTAL STRUCTURE OF K15R/E18D/Y22W/H41G/F44W/E51D/E53P/K57R/E60D/Y64W/H82G/F85W/E90D/E94P /K98R/E101D/Y108W/H129G/F132W/E137D SYMFOIL-4P: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
488, 3o4dA, 0.7397, 2.03, 0.133, 123, 113, CRYSTAL STRUCTURE OF SYMFOIL-4P: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
489, 3akgA, 0.7397, 2.29, 0.043, 447, 115, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE COMPLEXED WITH ALPHA-15-L-ARABINOFURANOBIOSE
490, 4kejA, 0.7396, 2.63, 0.092, 172, 119, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT R169Q
491, 3im7A, 0.7395, 2.61, 0.092, 174, 119, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 N-TERMINAL DOMAIN (1-217) DISEASE MUTANT A77V
492, 3akiA, 0.7394, 2.28, 0.043, 448, 115, CRYSTAL STRUCTURE OF EXO-15-ALPHA-L-ARABINOFURANOSIDASE COMPLEXED WITH ALPHA-L-ARABINOFURANOSYL AZIDO
493, 4f34A, 0.7392, 2.03, 0.124, 123, 113, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
494, 2lieA, 0.7387, 2.41, 0.112, 153, 116, NMR STRUCTURE OF THE LECTIN CCL2
495, 4lo8D, 0.7386, 2.54, 0.164, 143, 116, HA70(D3)-HA17
496, 5gugB, 0.7385, 2.65, 0.091, 1720, 121, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
497, 3o4cA, 0.7385, 2.04, 0.124, 124, 113, CRYSTAL STRUCTURE OF SYMFOIL-4V: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
498, 3vwcA, 0.7382, 3.00, 0.107, 146, 121, HIGH RESOLUTION STRUCTURE OF PROTEINASE INHIBITOR FROM COPRINOPSIS CINEREA
499, 3o4bA, 0.7382, 2.04, 0.115, 123, 113, CRYSTAL STRUCTURE OF SYMFOIL-4T: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
500, 6dqsD, 0.7381, 2.84, 0.090, 2192, 122, struct.pdbx_descriptor               Inositol 1;4;5-trisphosphate receptor type 3  
501, 3t8sB, 0.7381, 2.77, 0.082, 482, 122, APO AND INSP3-BOUND CRYSTAL STRUCTURES OF THE LIGAND-BINDING DOMAIN OF AN INSP3 RECEPTOR
502, 3n0kA, 0.7381, 2.99, 0.107, 150, 121, PROTEINASE INHIBITOR FROM COPRINOPSIS CINEREA
503, 3winC, 0.7380, 2.49, 0.165, 141, 115, CLOSTRIDIUM BOTULINUM HEMAGGLUTININ
504, 4keiA, 0.7378, 2.62, 0.092, 173, 119, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT P164S
505, 4f34B, 0.7376, 2.06, 0.124, 123, 113, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
506, 2e4mC, 0.7375, 2.49, 0.155, 143, 116, CRYSTAL STRUCTURE OF HEMAGGLUTININ SUBCOMPONENT COMPLEX (HA- 33/HA-17) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
507, 2mc2A, 0.7374, 2.45, 0.085, 206, 118, X-RAY CRYSTALLOGRAPHY-SOLUTION NMR HYBRID STRUCTURE OF MOUSE RYR2 DOMAIN A
508, 2y9gA, 0.7367, 2.83, 0.132, 147, 121, HIGH-RESOLUTION STRUCTURAL INSIGHTS ON THE SUGAR-RECOGNITION AND FUSION TAG PROPERTIES OF A VERSATILE B-TREFOIL LECTIN DOMAIN
509, 3im5A, 0.7366, 2.45, 0.085, 173, 118, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (RESIDUES 1-217)
510, 3o4aB, 0.7365, 2.05, 0.115, 123, 113, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
511, 2ffvA, 0.7365, 2.13, 0.114, 489, 114, HUMAN PPGALNACT-2 COMPLEXED WITH MANGANESE AND UDP
512, 5g56A, 0.7363, 2.48, 0.231, 703, 117, THE TETRA-MODULAR CELLULOSOMAL ARABINOXYLANASE CTXYL5A STRUCTURE AS REVEALED BY X-RAY CRYSTALLOGRAPHY
513, 3o4aA, 0.7363, 2.06, 0.115, 123, 113, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
514, 5xa1A, 0.7362, 2.72, 0.083, 1257, 121, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
515, 3uj4A, 0.7362, 2.86, 0.099, 486, 121, CRYSTAL STRUCTURE OF THE APO-INOSITOL 145-TRISPHOSPHATE RECEPTOR
516, 3im6A, 0.7361, 2.63, 0.092, 173, 119, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 MUTANT V186M
517, 3o49A, 0.7359, 2.06, 0.115, 123, 113, CRYSTAL STRUCTURE OF SYMFOIL-1: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
518, 3o4aC, 0.7358, 2.06, 0.115, 123, 113, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
519, 3o4aD, 0.7355, 2.06, 0.115, 123, 113, CRYSTAL STRUCTURE OF SYMFOIL-2: DE NOVO DESIGNED BETA-TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
520, 2ffvB, 0.7353, 2.16, 0.114, 481, 114, HUMAN PPGALNACT-2 COMPLEXED WITH MANGANESE AND UDP
521, 5xa1B, 0.7346, 2.72, 0.083, 1257, 121, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN WITH INOSITOL 145-TRISPHOSPHATE
522, 4f34D, 0.7344, 2.02, 0.125, 122, 112, SYMFOIL-4V SYNTHETIC PROTEIN WITH T30E/T72E/T116E MUTATIONS AND DELTA HIS TAG
523, 2m49A, 0.7314, 2.22, 0.096, 126, 115, STRUCTURAL INSIGHTS INTO HUMAN S100B AND BASIC FIBROBLAST GROWTH FACTOR (FGF2) INTERACTION
524, 5y9vA, 0.7313, 2.56, 0.093, 177, 118, CRYSTAL STURCTURE OF DIAMONDBACK MOTH RYANODINE RECEPTOR N-TERMINAL DOMAIN
525, 2hz9A, 0.7313, 2.35, 0.103, 141, 116, CRYSTAL STRUCTURE OF LYS12VAL/ASN95VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.70 ANGSTROM RESOLUTION.
526, 2vuaA, 0.7307, 2.73, 0.082, 423, 122, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN
527, 2m49C, 0.7304, 2.23, 0.096, 126, 115, STRUCTURAL INSIGHTS INTO HUMAN S100B AND BASIC FIBROBLAST GROWTH FACTOR (FGF2) INTERACTION
528, 5jlvB, 0.7303, 2.71, 0.082, 425, 122, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
529, 4i0yA, 0.7303, 2.73, 0.059, 473, 119, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT C36R
530, 4i3nA, 0.7297, 2.68, 0.059, 482, 118, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT D61N
531, 3fjdB, 0.7295, 2.40, 0.095, 141, 116, CRYSTAL STRUCTURE OF L44F/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
532, 3k1xA, 0.7294, 2.41, 0.103, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
533, 2ntdB, 0.7292, 2.39, 0.103, 143, 116, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
534, 4q9gA, 0.7290, 2.37, 0.121, 142, 116, CRYSTAL STRUCTURE OF K12V/C16S/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
535, 2ntdD, 0.7290, 2.39, 0.103, 142, 116, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
536, 2hz9B, 0.7290, 2.38, 0.095, 142, 116, CRYSTAL STRUCTURE OF LYS12VAL/ASN95VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.70 ANGSTROM RESOLUTION.
537, 3jutA, 0.7289, 2.35, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
538, 1hknC, 0.7289, 2.39, 0.112, 129, 116, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
539, 3r4uA, 0.7288, 2.61, 0.058, 422, 120, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
540, 2hwmA, 0.7288, 2.39, 0.112, 141, 116, CRYSTAL STRUCTURE OF LYS12VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION
541, 3halA, 0.7287, 2.36, 0.095, 131, 116, CRYSTAL STRUCTURE OF RABBIT ACIDIC FIBROBLAST GROWTH FACTOR
542, 1hknE, 0.7287, 2.34, 0.112, 130, 116, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
543, 3k1xF, 0.7286, 2.33, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
544, 2ntdC, 0.7285, 2.39, 0.121, 142, 116, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
545, 2afgA, 0.7285, 2.30, 0.113, 129, 115, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
546, 4q91A, 0.7284, 2.39, 0.112, 141, 116, CRYSTAL STRUCTURE OF C16A/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
547, 3jutC, 0.7284, 2.38, 0.103, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
548, 3jutB, 0.7284, 2.39, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
549, 3fjkA, 0.7284, 2.39, 0.103, 142, 116, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
550, 2fdbN, 0.7284, 2.43, 0.060, 148, 117, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR (FGF)8B IN COMPLEX WITH FGF RECEPTOR (FGFR) 2C
551, 2fdbM, 0.7284, 2.43, 0.060, 149, 117, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR (FGF)8B IN COMPLEX WITH FGF RECEPTOR (FGFR) 2C
552, 5jmcG, 0.7282, 2.72, 0.082, 419, 122, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
553, 3n7kA, 0.7282, 2.62, 0.058, 422, 120, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
554, 3ud8A, 0.7280, 2.38, 0.103, 129, 116, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
555, 3ojvB, 0.7279, 2.36, 0.112, 133, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
556, 3k1xB, 0.7279, 2.41, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
557, 3ojvA, 0.7278, 2.36, 0.112, 133, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR1C EXHIBITING AN ORDERED LIGAND SPECIFICITY-DETERMINING BETAC -BETAE LOOP
558, 3fjkD, 0.7278, 2.34, 0.104, 141, 115, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
559, 3fjjB, 0.7278, 2.39, 0.112, 141, 116, CRYSTAL STRUCTURE OF C83V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
560, 3fgmA, 0.7277, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF L44F/C83T/C117V/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
561, 1jtcB, 0.7277, 2.41, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
562, 3jutE, 0.7276, 2.34, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
563, 3fjeB, 0.7275, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF C83S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
564, 3fj9B, 0.7274, 2.40, 0.112, 141, 116, CRYSTAL STRUCTURE OF F85W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
565, 1nzkB, 0.7274, 2.39, 0.112, 141, 116, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
566, 1jt7B, 0.7274, 2.40, 0.112, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
567, 4i2sA, 0.7273, 2.62, 0.060, 482, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT I404M
568, 3fjcA, 0.7273, 2.40, 0.121, 141, 116, CRYSTAL STRUCTURE OF L44W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
569, 3fj9A, 0.7273, 2.40, 0.121, 141, 116, CRYSTAL STRUCTURE OF F85W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
570, 3fgmB, 0.7273, 2.42, 0.103, 141, 116, CRYSTAL STRUCTURE OF L44F/C83T/C117V/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
571, 2j3pB, 0.7273, 2.38, 0.103, 132, 116, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
572, 1jtcD, 0.7273, 2.41, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
573, 3fjaA, 0.7272, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
574, 3fjdA, 0.7271, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF L44F/F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
575, 1jqzB, 0.7271, 2.40, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG.
576, 3homB, 0.7270, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF OXIDIZED A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
577, 2ntdA, 0.7270, 2.40, 0.121, 142, 116, HUMAN FIBROBLAST GROWTH FACTOR-1 (140 AMINO ACID FORM) WITH CYS117VAL/PRO134CYS MUTATIONS
578, 2hw9A, 0.7270, 2.40, 0.112, 141, 116, CRYSTAL STRUCTURE OF LYS12CYS/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION.
579, 1evtB, 0.7270, 2.39, 0.112, 131, 116, CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1)
580, 1evtA, 0.7270, 2.40, 0.112, 131, 116, CRYSTAL STRUCTURE OF FGF1 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 1 (FGFR1)
581, 4fvvA, 0.7269, 2.70, 0.066, 412, 122, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
582, 3n7kB, 0.7269, 2.91, 0.057, 421, 122, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 BINDING DOMAIN
583, 3fjfA, 0.7269, 2.40, 0.112, 141, 116, CRYSTAL STRUCTURE OF C83T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
584, 4qbcB, 0.7268, 2.39, 0.112, 142, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM FORMATE BUFFER
585, 3criB, 0.7268, 2.39, 0.103, 142, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER GLU82ASN AND LYS101ALA
586, 1jt7D, 0.7268, 2.40, 0.112, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
587, 4i6iA, 0.7267, 2.79, 0.059, 451, 119, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-559) DISEASE MUTANT R45C
588, 3k1xE, 0.7267, 2.36, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
589, 3halB, 0.7267, 2.39, 0.095, 131, 116, CRYSTAL STRUCTURE OF RABBIT ACIDIC FIBROBLAST GROWTH FACTOR
590, 3fjkB, 0.7267, 2.39, 0.103, 141, 116, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
591, 3bahA, 0.7267, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF K112N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
592, 1jt4A, 0.7267, 2.40, 0.121, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND VAL 109 REPLACED BY LEU (V109L)
593, 4qbvA, 0.7266, 2.38, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM CITRATE BUFFER
594, 2fgfA, 0.7266, 2.28, 0.096, 126, 115, THREE-DIMENSIONAL STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR A STRUCTURAL HOMOLOG OF INTERLEUKIN 1BETA
595, 4qbcA, 0.7265, 2.39, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM FORMATE BUFFER
596, 4kekA, 0.7265, 2.44, 0.086, 167, 116, CRYSTAL STRUCTURE OF MOUSE RYANODINE RECEPTOR 2 (1-217) DISEASE MUTANT R176Q
597, 4ow4A, 0.7264, 2.18, 0.115, 123, 113, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
598, 3baqA, 0.7264, 2.40, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
599, 1jtcC, 0.7264, 2.40, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
600, 3bauB, 0.7263, 2.41, 0.121, 141, 116, CRYSTAL STRUCTURE OF K12V/L26D/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
601, 1jy0A, 0.7263, 2.40, 0.112, 140, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND CYS 117 REPLACED WITH VAL (C117V).
602, 3fjaB, 0.7262, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF F132W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
603, 2hwaA, 0.7262, 2.40, 0.112, 140, 116, CRYSTAL STRUCTURE OF LYS12THR/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.65 ANGSTROM RESOLUTION.
604, 2afgB, 0.7262, 2.33, 0.113, 129, 115, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
605, 1jqzA, 0.7262, 2.41, 0.112, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG.
606, 1hknD, 0.7262, 2.32, 0.113, 129, 115, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
607, 1bfgA, 0.7262, 2.28, 0.096, 126, 115, CRYSTAL STRUCTURE OF BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION
608, 3ojmA, 0.7261, 2.40, 0.112, 145, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING P253R APERT MUTATION
609, 3criA, 0.7261, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER GLU82ASN AND LYS101ALA
610, 3crhB, 0.7261, 2.40, 0.103, 142, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER AND LYS101ALA
611, 3baoA, 0.7261, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF L26N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
612, 3badA, 0.7261, 2.39, 0.112, 131, 116, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
613, 1q04B, 0.7261, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF FGF-1 S50E/V51N
614, 1q04A, 0.7261, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF FGF-1 S50E/V51N
615, 1jt4B, 0.7261, 2.41, 0.112, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND VAL 109 REPLACED BY LEU (V109L)
616, 3bauA, 0.7260, 2.41, 0.121, 141, 116, CRYSTAL STRUCTURE OF K12V/L26D/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
617, 1p63B, 0.7260, 2.40, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 140 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU111 REPLACED WITH ILE (L111I)
618, 4qc4A, 0.7259, 2.39, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
619, 3ba7B, 0.7259, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26N/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
620, 2hwmB, 0.7259, 2.43, 0.103, 141, 116, CRYSTAL STRUCTURE OF LYS12VAL/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION
621, 1nzkD, 0.7259, 2.41, 0.112, 141, 116, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
622, 1jtcA, 0.7259, 2.40, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE (L44F)
623, 3r4sA, 0.7258, 2.64, 0.058, 424, 120, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
624, 3cqaB, 0.7258, 2.42, 0.103, 141, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA AND LYS101ALA
625, 1rg8A, 0.7258, 2.41, 0.112, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (HAFGF-1) AT 1.10 ANGSTROM RESOLUTION (140 AMINO ACID FORM)
626, 3fjfB, 0.7257, 2.40, 0.112, 142, 116, CRYSTAL STRUCTURE OF C83T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
627, 3fjcB, 0.7257, 2.42, 0.121, 141, 116, CRYSTAL STRUCTURE OF L44W MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
628, 3ba5A, 0.7257, 2.41, 0.121, 141, 116, CRYSTAL STRUCTURE OF D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
629, 3b9uA, 0.7257, 2.39, 0.103, 132, 116, CRYSTAL STRUCTURE OF L26N/D28N/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
630, 2xoaA, 0.7257, 2.79, 0.059, 461, 118, CRYSTAL STRUCTURE OF THE N-TERMINAL THREE DOMAINS OF THE SKELETAL MUSCLE RYANODINE RECEPTOR (RYR1)
631, 5g37B, 0.7256, 2.59, 0.121, 420, 116, MR STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 5
632, 3fjhB, 0.7256, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF C83A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
633, 3bb2B, 0.7256, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26D/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
634, 3bb2A, 0.7256, 2.41, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26D/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
635, 3bavA, 0.7256, 2.41, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26A/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
636, 3ba5B, 0.7256, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
637, 3ba4A, 0.7256, 2.41, 0.112, 144, 116, CRYSTAL STRUCTURE OF L26D MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
638, 4q9pB, 0.7255, 2.41, 0.103, 140, 116, CRYSTAL STRUCTURE OF C16T/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
639, 3jutD, 0.7255, 2.41, 0.103, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
640, 3baoB, 0.7255, 2.42, 0.103, 142, 116, CRYSTAL STRUCTURE OF L26N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
641, 1m16A, 0.7255, 2.41, 0.121, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED WITH PHE (L44F) LEU 73 REPLACED WITH VAL (L73V) VAL 109 REPLACED WITH LEU (V109L) AND CYS 117 REPLACED WITH VAL (C117V).
642, 4q9gB, 0.7254, 2.43, 0.112, 142, 116, CRYSTAL STRUCTURE OF K12V/C16S/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
643, 3homA, 0.7254, 2.40, 0.112, 141, 116, CRYSTAL STRUCTURE OF OXIDIZED A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
644, 3crgB, 0.7254, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA GLU82ASN AND LYS101ALA
645, 3k1xC, 0.7253, 2.42, 0.103, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
646, 3fjbA, 0.7253, 2.41, 0.121, 140, 116, CRYSTAL STRUCTURE OF V31I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
647, 1jy0B, 0.7253, 2.43, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND CYS 117 REPLACED WITH VAL (C117V).
648, 3r4sB, 0.7252, 2.65, 0.058, 424, 120, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
649, 3fjiA, 0.7252, 2.41, 0.103, 140, 116, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
650, 3fj8A, 0.7252, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF C117I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
651, 3crhA, 0.7252, 2.41, 0.103, 142, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81SER AND LYS101ALA
652, 3bavB, 0.7252, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26A/D28N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
653, 3bahB, 0.7252, 2.42, 0.103, 142, 116, CRYSTAL STRUCTURE OF K112N MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
654, 3ba7A, 0.7252, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26N/D28A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
655, 1k5uA, 0.7252, 2.33, 0.104, 129, 115, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
656, 6es1A, 0.7251, 2.93, 0.081, 420, 123, CRYSTAL STRUCTURE OF THE BINDING DOMAIN FROM BOTULINUM NEUROTOXIN A2 BOUND TO EXTRACELLULAR DOMAIN OF HUMAN RECEPTOR SV2C 
657, 5tpcA, 0.7251, 2.78, 0.082, 425, 122, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE
658, 3jutF, 0.7251, 2.37, 0.112, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH GENTISIC ACID
659, 3fjkC, 0.7251, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF A66C MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
660, 3badB, 0.7251, 2.32, 0.104, 129, 115, CRYSTAL STRUCTURE OF D70A/H93G MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
661, 1q03B, 0.7251, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF FGF-1 S50G/V51G MUTANT
662, 5jmcA, 0.7250, 2.77, 0.082, 420, 122, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
663, 3udaC, 0.7250, 2.31, 0.113, 129, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
664, 3fjjA, 0.7250, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF C83V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
665, 3fjeA, 0.7250, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF C83S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
666, 3baqB, 0.7250, 2.42, 0.112, 141, 116, CRYSTAL STRUCTURE OF L26A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
667, 3ba4B, 0.7250, 2.42, 0.112, 144, 116, CRYSTAL STRUCTURE OF L26D MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
668, 2hwaB, 0.7250, 2.42, 0.103, 141, 116, CRYSTAL STRUCTURE OF LYS12THR/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.65 ANGSTROM RESOLUTION.
669, 1nzkC, 0.7250, 2.41, 0.121, 141, 116, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
670, 5lr0B, 0.7249, 2.75, 0.066, 412, 122, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
671, 4qalA, 0.7249, 2.41, 0.103, 142, 116, CRYSTAL STRUCTURE OF C117A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
672, 1ry7A, 0.7249, 2.40, 0.103, 151, 116, CRYSTAL STRUCTURE OF THE 3 IG FORM OF FGFR3C IN COMPLEX WITH FGF1
673, 4goyB, 0.7248, 2.06, 0.062, 484, 112, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
674, 1q03A, 0.7248, 2.41, 0.112, 141, 116, CRYSTAL STRUCTURE OF FGF-1 S50G/V51G MUTANT
675, 1nzkA, 0.7248, 2.42, 0.121, 141, 116, CRYSTAL STRUCTURE OF A MULTIPLE MUTANT (L44F L73V V109L L111I C117V) OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
676, 1k5uC, 0.7248, 2.33, 0.104, 129, 115, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
677, 5lr0A, 0.7247, 2.69, 0.066, 407, 121, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH SIALYLT
678, 1rg8B, 0.7247, 2.41, 0.103, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (HAFGF-1) AT 1.10 ANGSTROM RESOLUTION (140 AMINO ACID FORM)
679, 1pzzB, 0.7247, 2.42, 0.103, 142, 116, CRYSTAL STRUCTURE OF FGF-1 V51N MUTANT
680, 1jt7C, 0.7247, 2.41, 0.121, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
681, 1cvsB, 0.7247, 2.35, 0.095, 129, 116, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
682, 4yolB, 0.7246, 2.43, 0.112, 143, 116, HUMAN FIBROBLAST GROWTH FACTOR-1 C16S/A66C/C117A/P134A
683, 3fjbB, 0.7246, 2.44, 0.112, 140, 116, CRYSTAL STRUCTURE OF V31I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
684, 1p63A, 0.7246, 2.41, 0.112, 140, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 140 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU111 REPLACED WITH ILE (L111I)
685, 3cqaA, 0.7245, 2.42, 0.103, 140, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA AND LYS101ALA
686, 2bfhA, 0.7245, 2.30, 0.096, 128, 115, CRYSTAL STRUCTURE OF BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION
687, 1ev2A, 0.7245, 2.37, 0.095, 130, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
688, 4yolA, 0.7244, 2.42, 0.112, 143, 116, HUMAN FIBROBLAST GROWTH FACTOR-1 C16S/A66C/C117A/P134A
689, 4q91B, 0.7244, 2.44, 0.112, 142, 116, CRYSTAL STRUCTURE OF C16A/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
690, 4i7iA, 0.7244, 2.76, 0.059, 485, 119, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT L14R
691, 3fjiC, 0.7244, 2.44, 0.112, 142, 116, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
692, 1pzzA, 0.7244, 2.42, 0.112, 140, 116, CRYSTAL STRUCTURE OF FGF-1 V51N MUTANT
693, 1m16B, 0.7244, 2.44, 0.112, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED WITH PHE (L44F) LEU 73 REPLACED WITH VAL (L73V) VAL 109 REPLACED WITH LEU (V109L) AND CYS 117 REPLACED WITH VAL (C117V).
694, 1ev2D, 0.7244, 2.37, 0.095, 130, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
695, 1cvsA, 0.7244, 2.36, 0.095, 129, 116, CRYSTAL STRUCTURE OF A DIMERIC FGF2-FGFR1 COMPLEX
696, 4xkiB, 0.7243, 2.38, 0.112, 144, 116, HUMAN FIBROBLAST GROWTH FACTOR - 1 (FGF-1) MUTANT S116R
697, 4qc4B, 0.7243, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117S MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
698, 4qbvB, 0.7243, 2.40, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117T MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN SODIUM CITRATE BUFFER
699, 1jt3A, 0.7243, 2.42, 0.103, 143, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO HISTIDINE TAG AND LEU 73 REPLACED BY VAL (L73V)
700, 1ev2C, 0.7243, 2.37, 0.095, 130, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
701, 1ev2B, 0.7243, 2.37, 0.095, 130, 116, CRYSTAL STRUCTURE OF FGF2 IN COMPLEX WITH THE EXTRACELLULAR LIGAND BINDING DOMAIN OF FGF RECEPTOR 2 (FGFR2)
702, 3fjhA, 0.7242, 2.42, 0.103, 141, 116, CRYSTAL STRUCTURE OF C83A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
703, 1jt5A, 0.7242, 2.41, 0.121, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L73V/V109L)
704, 4q9pA, 0.7241, 2.40, 0.103, 131, 116, CRYSTAL STRUCTURE OF C16T/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
705, 3wa1A, 0.7241, 2.46, 0.122, 389, 115, CRYSTAL STRUCTURE OF BINB: A RECEPTOR BINDING COMPONENT OF THE BINARY TOXIN FROM LYSINIBACILLUS SPHAERICUS
706, 3bagA, 0.7241, 2.41, 0.112, 141, 116, CRYSTAL STRUCTURE OF K112N/N114A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
707, 4ow4B, 0.7240, 2.21, 0.115, 123, 113, BETA-TREFOIL DESIGNED BY FOLDING NUCLEUS SYMMETRIC EXPANSION (PHIFOIL)
708, 4i1eA, 0.7240, 2.84, 0.059, 484, 119, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT G249R
709, 2hw9B, 0.7240, 2.44, 0.103, 141, 116, CRYSTAL STRUCTURE OF LYS12CYS/CYS117VAL MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR AT 1.60 ANGSTROM RESOLUTION.
710, 1jt7A, 0.7240, 2.42, 0.121, 141, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 44 REPLACED BY PHE AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L44F/L73V/V109L)
711, 1jt3B, 0.7239, 2.43, 0.103, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO HISTIDINE TAG AND LEU 73 REPLACED BY VAL (L73V)
712, 1iilC, 0.7239, 2.37, 0.095, 132, 116, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
713, 4qalB, 0.7238, 2.41, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
714, 4gp0B, 0.7238, 2.06, 0.062, 483, 112, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
715, 3v0cA, 0.7238, 2.97, 0.081, 1277, 123, 4.3 ANGSTROM CRYSTAL STRUCTURE OF AN INACTIVE BONT/A (E224Q/R363A/Y366F)
716, 1ii4A, 0.7238, 2.37, 0.095, 134, 116, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
717, 1hknA, 0.7238, 2.35, 0.104, 128, 115, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
718, 1fq9B, 0.7238, 2.37, 0.095, 129, 116, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
719, 5tpbB, 0.7237, 2.76, 0.082, 407, 122, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
720, 4i4pB, 0.7237, 2.79, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 2
721, 1fq9A, 0.7237, 2.37, 0.095, 129, 116, CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX
722, 1ii4B, 0.7236, 2.38, 0.095, 134, 116, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
723, 5jmcE, 0.7235, 2.75, 0.090, 419, 122, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
724, 1iilD, 0.7235, 2.37, 0.095, 132, 116, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
725, 3fj8B, 0.7234, 2.44, 0.103, 141, 116, CRYSTAL STRUCTURE OF C117I MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
726, 1iilB, 0.7234, 2.38, 0.095, 133, 116, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
727, 4i4xD, 0.7233, 2.81, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
728, 3fuoA, 0.7233, 2.95, 0.089, 416, 123, THE CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A
729, 3crgA, 0.7233, 2.44, 0.103, 141, 116, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR-1 WITH MUTATIONS GLU81ALA GLU82ASN AND LYS101ALA
730, 1iilA, 0.7233, 2.38, 0.095, 134, 116, CRYSTAL STRUCTURE OF PRO253ARG APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
731, 3bagB, 0.7232, 2.44, 0.103, 141, 116, CRYSTAL STRUCTURE OF K112N/N114A MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
732, 1ii4D, 0.7232, 2.38, 0.095, 134, 116, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
733, 1ii4C, 0.7232, 2.38, 0.095, 134, 116, CRYSTAL STRUCTURE OF SER252TRP APERT MUTANT FGF RECEPTOR 2 (FGFR2) IN COMPLEX WITH FGF2
734, 1bffA, 0.7232, 2.37, 0.095, 129, 116, THE 154 AMINO ACID FORM OF HUMAN BASIC FIBROBLAST GROWTH FACTOR
735, 4i4pA, 0.7231, 2.81, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 2
736, 4i37A, 0.7230, 2.72, 0.059, 466, 118, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT R402G
737, 4xkiA, 0.7229, 2.42, 0.112, 145, 116, HUMAN FIBROBLAST GROWTH FACTOR - 1 (FGF-1) MUTANT S116R
738, 3fjiB, 0.7229, 2.44, 0.103, 142, 116, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
739, 1jt5B, 0.7229, 2.43, 0.112, 142, 116, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG AND LEU 73 REPLACED BY VAL AND VAL 109 REPLACED BY LEU (L73V/V109L)
740, 4i4rD, 0.7228, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 4
741, 1e0oC, 0.7228, 2.45, 0.103, 130, 116, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
742, 2axmA, 0.7227, 2.49, 0.103, 130, 116, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
743, 1g9cA, 0.7227, 3.01, 0.065, 1287, 124, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4)
744, 4i4sB, 0.7226, 2.83, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
745, 3k1xD, 0.7226, 2.46, 0.103, 130, 116, ACIDIC FIBROBLAST GROWTH FACTOR (FGF-1) COMPLEXED WITH DOBESILATE
746, 6b0tD, 0.7225, 2.08, 0.062, 487, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
747, 4qo3B, 0.7225, 2.46, 0.112, 141, 116, CRYSTAL STRUCTURE OF C16S/N18S/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
748, 4qo3A, 0.7225, 2.45, 0.112, 142, 116, CRYSTAL STRUCTURE OF C16S/N18S/K12V/C117V/P134V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
749, 3fjiD, 0.7225, 2.44, 0.112, 139, 116, CRYSTAL STRUCTURE OF K12V/C83I/C117V MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
750, 3o3qB, 0.7224, 2.17, 0.125, 122, 112, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
751, 5jmcC, 0.7223, 2.76, 0.082, 417, 122, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH RAT SV2C
752, 3o3qA, 0.7223, 2.17, 0.125, 123, 112, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
753, 1e0oA, 0.7221, 2.39, 0.104, 129, 115, CRYSTAL STRUCTURE OF A TERNARY FGF1-FGFR2-HEPARIN COMPLEX
754, 5moyA, 0.7220, 2.88, 0.081, 414, 123, CRYSTAL STRUCTURE OF THE BONT/A2 RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF ITS NEURONAL RECEPTOR SV2C
755, 5fozB, 0.7220, 2.48, 0.122, 419, 115, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 10
756, 2nz9A, 0.7220, 2.99, 0.081, 1267, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
757, 4tlwA, 0.7219, 3.09, 0.104, 567, 125, CARDS TOXIN FULL-LENGTH
758, 4i4uB, 0.7218, 2.82, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
759, 3oj2B, 0.7218, 2.45, 0.103, 135, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
760, 3n7lA, 0.7218, 2.69, 0.066, 418, 121, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D/C VPI 5993 BINDING DOMAIN
761, 4i4yD, 0.7217, 2.82, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
762, 3ud9B, 0.7217, 2.35, 0.113, 128, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
763, 3ud8C, 0.7217, 2.34, 0.113, 129, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
764, 3oj2A, 0.7217, 2.45, 0.103, 135, 116, CRYSTAL STRUCTURE OF FGF1 COMPLEXED WITH THE ECTODOMAIN OF FGFR2B HARBORING THE A172F PFEIFFER SYNDROME MUTATION
765, 3llpB, 0.7217, 2.11, 0.062, 478, 112, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
766, 1djsB, 0.7217, 2.44, 0.103, 134, 116, LIGAND-BINDING PORTION OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 IN COMPLEX WITH FGF1
767, 4fvvB, 0.7216, 2.75, 0.066, 415, 122, CRYSTAL STRUCTURE OF HCR/D-SA-GBL1/C
768, 2nyyA, 0.7216, 2.98, 0.089, 1267, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
769, 1hknF, 0.7216, 2.35, 0.113, 128, 115, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
770, 3llpA, 0.7215, 2.03, 0.063, 472, 111, 1.8 ANGSTROM HUMAN FASCIN 1 CRYSTAL STRUCTURE
771, 4isqC, 0.7214, 2.75, 0.074, 414, 122, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
772, 4i4sD, 0.7213, 2.85, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
773, 1k5vA, 0.7213, 2.37, 0.104, 128, 115, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH ASN106 REPLACED BY GLY (N106G).
774, 6b0tB, 0.7212, 2.12, 0.062, 487, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
775, 4i8mA, 0.7212, 2.71, 0.060, 480, 117, CRYSTAL STRUCTURE OF RABBIT RYANODINE RECEPTOR 1 (RESIDUES 1-536) DISEASE MUTANT V219I
776, 3ud8B, 0.7212, 2.37, 0.113, 128, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI22) COMPLEX
777, 2uusB, 0.7212, 2.45, 0.103, 129, 116, CRYSTAL STRUCTURE OF THE RAT FGF1-SUCROSE OCTASULFATE (SOS) COMPLEX.
778, 3cu1D, 0.7211, 2.49, 0.103, 131, 116, CRYSTAL STRUCTURE OF 2:2:2 FGFR2D2:FGF1:SOS COMPLEX
779, 1f31A, 0.7211, 2.81, 0.073, 1280, 123, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE
780, 4isqA, 0.7210, 2.76, 0.074, 414, 122, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
781, 3azwA, 0.7210, 2.72, 0.066, 418, 121, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
782, 2nz9B, 0.7210, 2.98, 0.089, 1267, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
783, 1i1eA, 0.7210, 2.85, 0.065, 1287, 123, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN
784, 1hknB, 0.7210, 2.38, 0.104, 128, 115, A COMPLEX BETWEEN ACIDIC FIBROBLAST GROWTH FACTOR AND 5-AMINO-2-NAPHTHALENESULFONATE
785, 5x1oB, 0.7209, 2.41, 0.095, 127, 116, PI(45)P2 LIPID BINDING INDUCED A REORIENTATION OF FGF2 MOLECULES NEAR MEMBRANE SURFACE TO FACILITATE THE UNCONVENTIONAL OLIGOMERIZATION- DEPENDENT SECRETION PROCESS AS REVEALED BY A COMBINED FTIR/NMR/X-RAY STUDY
786, 4i4uC, 0.7209, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
787, 5foyB, 0.7208, 2.49, 0.122, 421, 115, DE NOVO STRUCTURE OF THE BINARY MOSQUITO LARVICIDE BINAB AT PH 7
788, 4i4oB, 0.7208, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 1
789, 5x1oA, 0.7207, 2.41, 0.095, 127, 116, PI(45)P2 LIPID BINDING INDUCED A REORIENTATION OF FGF2 MOLECULES NEAR MEMBRANE SURFACE TO FACILITATE THE UNCONVENTIONAL OLIGOMERIZATION- DEPENDENT SECRETION PROCESS AS REVEALED BY A COMBINED FTIR/NMR/X-RAY STUDY
790, 4i4rA, 0.7206, 2.84, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 4
791, 1axmA, 0.7206, 2.48, 0.103, 129, 116, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
792, 6b0tF, 0.7203, 2.10, 0.062, 487, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
793, 4i4vB, 0.7203, 2.85, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
794, 3o3qC, 0.7203, 2.30, 0.115, 127, 113, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
795, 3n7mA, 0.7202, 2.92, 0.073, 418, 123, CRYSTAL STRUCTURE OF W1252A MUTANT OF HCR D/C VPI 5995
796, 4i4rB, 0.7201, 2.83, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 4
797, 4isrB, 0.7200, 2.71, 0.066, 413, 121, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
798, 4i4yA, 0.7200, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
799, 3azwB, 0.7200, 2.77, 0.066, 418, 122, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
800, 1barB, 0.7200, 2.41, 0.103, 138, 116, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
801, 6b0tE, 0.7197, 2.10, 0.062, 487, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
802, 4isrC, 0.7197, 2.77, 0.074, 413, 122, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
803, 4isqB, 0.7197, 2.71, 0.066, 413, 121, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH HUMAN SYNAPTOTAGMIN I
804, 1g9dA, 0.7197, 3.04, 0.065, 1287, 124, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2)
805, 4isrA, 0.7196, 2.77, 0.074, 414, 122, BINDING DOMAIN OF BOTULINUM NEUROTOXIN DC IN COMPLEX WITH RAT SYNAPTOTAGMIN II
806, 4i4sA, 0.7196, 2.87, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
807, 1axmF, 0.7196, 2.37, 0.113, 128, 115, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
808, 4i4vD, 0.7195, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
809, 1s0eA, 0.7195, 3.03, 0.065, 1287, 124, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0
810, 1s0dA, 0.7195, 2.86, 0.065, 1287, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5
811, 6b0tC, 0.7194, 2.28, 0.150, 487, 113, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
812, 3o3qD, 0.7194, 2.30, 0.124, 127, 113, CRYSTAL STRUCTURE OF L44F/M67I/L73V/A103G/DELETION 104- 106/F108Y/V109L/L111I/C117V/R119G/DELETION 120-122 MUTANT FORM OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
813, 4i4vC, 0.7193, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
814, 4i4rC, 0.7193, 2.73, 0.134, 146, 119, BEL BETA-TREFOIL APO CRYSTAL FORM 4
815, 1s0cA, 0.7193, 2.88, 0.065, 1287, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0
816, 3btaA, 0.7192, 3.01, 0.081, 1277, 123, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A
817, 6f0oA, 0.7191, 3.00, 0.089, 407, 123, BOTULINUM NEUROTOXIN A3 HC DOMAIN
818, 3rmyB, 0.7190, 2.99, 0.092, 398, 120, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
819, 2rq9A, 0.7189, 2.40, 0.112, 143, 116, SOLUTION STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR (AFGF) IN THE PRESENCE OF A PROTEIN STABILIZER NDSB-NEW
820, 1axmE, 0.7189, 2.38, 0.113, 128, 115, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
821, 4i4xA, 0.7188, 2.86, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
822, 4i4qA, 0.7188, 2.85, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 3
823, 4i4yB, 0.7187, 2.87, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
824, 3oggA, 0.7187, 3.01, 0.074, 404, 121, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN D
825, 1basA, 0.7187, 2.28, 0.096, 125, 114, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
826, 4i4uD, 0.7186, 2.87, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
827, 4i4sC, 0.7186, 2.89, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH LACTOSE
828, 3cu1B, 0.7186, 2.40, 0.104, 128, 115, CRYSTAL STRUCTURE OF 2:2:2 FGFR2D2:FGF1:SOS COMPLEX
829, 1g9bA, 0.7186, 3.05, 0.065, 1287, 124, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1)
830, 1epwA, 0.7186, 2.88, 0.065, 1287, 123, CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B
831, 4i4xB, 0.7185, 2.87, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
832, 3obrA, 0.7184, 3.01, 0.074, 418, 121, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
833, 3n7jA, 0.7181, 3.06, 0.083, 405, 121, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D BINDING DOMAIN
834, 1s0bA, 0.7179, 3.04, 0.065, 1287, 124, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0
835, 5mk7A, 0.7178, 2.84, 0.082, 397, 122, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 2)
836, 1z2vA, 0.7178, 2.40, 0.113, 140, 115, CRYSTAL STRUCTURE OF GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
837, 4iqpA, 0.7177, 3.02, 0.089, 419, 123, CRYSTAL STRUCTURE OF HCRA-W1266A
838, 4i4yC, 0.7177, 2.88, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN
839, 4i4xC, 0.7177, 2.89, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH T-ANTIGEN DISACCHARIDE
840, 4i4oA, 0.7177, 2.87, 0.133, 146, 120, BEL BETA-TREFOIL APO CRYSTAL FORM 1
841, 3ud7C, 0.7177, 2.33, 0.105, 127, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
842, 2aqzA, 0.7177, 2.41, 0.122, 140, 115, CRYSTAL STRUCTURE OF FGF-1 S17T/N18T/G19 DELETION MUTANT
843, 2afgC, 0.7177, 2.36, 0.096, 127, 114, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
844, 1afcF, 0.7177, 2.31, 0.114, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
845, 2aqzB, 0.7176, 2.40, 0.104, 141, 115, CRYSTAL STRUCTURE OF FGF-1 S17T/N18T/G19 DELETION MUTANT
846, 4oefA, 0.7175, 2.30, 0.096, 125, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S6I2) COMPLEX
847, 4gp0A, 0.7175, 2.32, 0.150, 477, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 R149A K150A R151A MUTANT
848, 1afcG, 0.7175, 2.32, 0.105, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
849, 4gp3A, 0.7174, 2.28, 0.150, 480, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
850, 1k5uB, 0.7173, 2.36, 0.096, 128, 114, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH HIS93 REPLACED BY GLY (H93G).
851, 1afcA, 0.7172, 2.34, 0.114, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
852, 3ud9A, 0.7171, 2.35, 0.096, 128, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
853, 3rmxA, 0.7171, 3.11, 0.066, 404, 121, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
854, 4govA, 0.7169, 2.29, 0.150, 470, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
855, 1afcD, 0.7169, 2.32, 0.114, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
856, 1afcC, 0.7169, 2.31, 0.114, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
857, 1z0hA, 0.7167, 2.82, 0.066, 438, 122, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
858, 3p53B, 0.7166, 2.34, 0.150, 484, 113, STRUCTURE OF FASCIN
859, 1dzcA, 0.7166, 2.31, 0.123, 131, 114, HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR. MUTANT FGF-4-ALA-(23-154) 24 NMR STRUCTURES
860, 1dllA, 0.7166, 2.96, 0.050, 441, 121, THE HC FRAGEMENT OF TETANUS TOXIN COMPLEXED WITH LACTOSE
861, 6b0tA, 0.7165, 2.14, 0.062, 487, 112, STRUCTURAL INSIGHTS INTO THE INDUCED-FIT INHIBITION OF FASCIN BY A SMALL MOLECULE 
862, 3ud7A, 0.7165, 2.37, 0.105, 127, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
863, 3hmyA, 0.7165, 2.97, 0.050, 442, 121, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2
864, 3hn1A, 0.7164, 2.98, 0.050, 442, 121, CRYSTAL STRUCTURE OF HCR/T COMPLEXED WITH GT2 AND LACTOSE
865, 1z2vB, 0.7164, 2.45, 0.103, 140, 116, CRYSTAL STRUCTURE OF GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
866, 4tlvD, 0.7163, 3.02, 0.099, 577, 121, CARDS TOXIN NICKED
867, 4i4uA, 0.7163, 2.90, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH GALACTOSE
868, 3obtA, 0.7163, 3.05, 0.074, 412, 121, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE D LIGAND BINDING DOMAIN IN COMPLEX WITH N-ACETYLNEURAMINIC ACID
869, 4jraA, 0.7162, 3.02, 0.081, 416, 123, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
870, 2q9xA, 0.7162, 2.33, 0.105, 127, 114, CRYSTAL STRUCTURE OF HIGHLY STABLE MUTANT Q40P/S47I/H93G OF HUMAN FIBROBLAST GROWTH FACTOR-1
871, 2uusA, 0.7161, 2.48, 0.103, 131, 116, CRYSTAL STRUCTURE OF THE RAT FGF1-SUCROSE OCTASULFATE (SOS) COMPLEX.
872, 1barA, 0.7161, 2.35, 0.105, 127, 114, THREE-DIMENSIONAL STRUCTURES OF ACIDIC AND BASIC FIBROBLAST GROWTH FACTORS
873, 4goyA, 0.7159, 2.30, 0.159, 475, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K41A MUTANT
874, 2afgD, 0.7159, 2.35, 0.096, 128, 114, 2.0 ANGSTROM X-RAY STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
875, 1afcB, 0.7159, 2.33, 0.105, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
876, 5mk8A, 0.7158, 3.01, 0.098, 421, 123, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
877, 4j23B, 0.7158, 2.46, 0.112, 134, 116, LOW RESOLUTION CRYSTAL STRUCTURE OF THE FGFR2D2D3/FGF1/SR128545 COMPLEX
878, 2j3pA, 0.7157, 2.48, 0.095, 134, 116, CRYSTAL STRUCTURE OF RAT FGF1 AT 1.4 A
879, 1ytoA, 0.7157, 2.41, 0.104, 139, 115, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
880, 4gp3B, 0.7156, 2.36, 0.150, 481, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 K358A MUTANT
881, 1ihkA, 0.7156, 2.45, 0.104, 157, 115, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 9 (FGF9)
882, 1bfcA, 0.7155, 2.27, 0.097, 124, 113, BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN HEXAMER FRAGMENT
883, 1bfbA, 0.7155, 2.26, 0.097, 124, 113, BASIC FIBROBLAST GROWTH FACTOR COMPLEXED WITH HEPARIN TETRAMER FRAGMENT
884, 1axmC, 0.7155, 2.42, 0.113, 127, 115, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
885, 5w59A, 0.7154, 2.43, 0.104, 146, 115, CRYSTAL STRUCTURE OF A MONOMERIC HUMAN FGF9 IN COMPLEX WITH THE ECTODOMAIN OF HUMAN FGFR1C
886, 4tlvF, 0.7154, 3.02, 0.099, 573, 121, CARDS TOXIN NICKED
887, 4govB, 0.7153, 2.33, 0.150, 483, 113, THE CRYSTAL STRUCTURE OF HUMAN FASCIN 1 S39D MUTANT
888, 4d0tF, 0.7153, 2.19, 0.117, 487, 111, GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC  EA2 PEPTIDE AND MANGANESE
889, 1ytoB, 0.7153, 2.41, 0.104, 141, 115, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
890, 1a8dA, 0.7153, 2.98, 0.050, 452, 121, TETANUS TOXIN C FRAGMENT
891, 1ytoD, 0.7151, 2.42, 0.104, 138, 115, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
892, 1afcH, 0.7151, 2.32, 0.114, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
893, 3p53A, 0.7150, 2.23, 0.143, 486, 112, STRUCTURE OF FASCIN
894, 5vidB, 0.7149, 2.81, 0.074, 412, 122, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
895, 4i4vA, 0.7149, 2.91, 0.133, 146, 120, BEL BETA-TREFOIL COMPLEX WITH N-ACETYLGALACTOSAMINE
896, 4tlvC, 0.7148, 3.04, 0.099, 577, 121, CARDS TOXIN NICKED
897, 4tlvA, 0.7147, 3.03, 0.099, 582, 121, CARDS TOXIN NICKED
898, 1dfqA, 0.7147, 2.98, 0.050, 441, 121, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH SIALIC ACID
899, 3udaB, 0.7144, 2.39, 0.096, 127, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
900, 4cjmA, 0.7143, 2.48, 0.103, 129, 116, CRYSTAL STRUCTURE OF HUMAN FGF18
901, 4tlvE, 0.7141, 3.03, 0.099, 582, 121, CARDS TOXIN NICKED
902, 1yxwA, 0.7140, 3.00, 0.050, 441, 121, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
903, 1g82C, 0.7140, 2.47, 0.104, 155, 115, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
904, 1g82B, 0.7140, 2.44, 0.104, 157, 115, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
905, 2nm1A, 0.7139, 2.83, 0.074, 430, 122, STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR
906, 2ermA, 0.7138, 2.57, 0.121, 133, 116, SOLUTION STRUCTURE OF A BIOLOGICALLY ACTIVE HUMAN FGF-1 MONOMER COMPLEXED TO A HEXASACCHARIDE HEPARIN-ANALOGUE
907, 5mk8B, 0.7137, 3.04, 0.089, 420, 123, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF THE FA HYBRID CLOSTRIDIUM BOTULINUM NEUROTOXIN
908, 3rmyC, 0.7137, 3.13, 0.082, 403, 122, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
909, 3rmyA, 0.7137, 2.89, 0.092, 401, 119, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
910, 1afcE, 0.7137, 2.35, 0.114, 127, 114, STRUCTURAL STUDIES OF THE BINDING OF THE ANTI-ULCER DRUG SUCROSE OCTASULFATE TO ACIDIC FIBROBLAST GROWTH FACTOR
911, 5vidE, 0.7136, 2.75, 0.066, 405, 121, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
912, 3h6qA, 0.7136, 3.01, 0.092, 168, 120, MACROCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
913, 1yynA, 0.7136, 3.00, 0.050, 441, 121, A COMMON BINDING SITE FOR DISIALYLLACTOSE AND A TRI-PEPTIDE IN THE C-FRAGMENT OF TETANUS NEUROTOXIN
914, 2axmB, 0.7135, 2.41, 0.105, 127, 114, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
915, 1fv3A, 0.7135, 2.84, 0.050, 451, 120, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
916, 3ud9C, 0.7134, 2.39, 0.105, 127, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI23) COMPLEX
917, 2vxrA, 0.7134, 2.98, 0.081, 428, 123, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN
918, 1g82A, 0.7134, 2.46, 0.096, 157, 115, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
919, 5vidD, 0.7132, 2.89, 0.073, 420, 123, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
920, 4tlvB, 0.7132, 3.05, 0.099, 580, 121, CARDS TOXIN NICKED
921, 4oeeA, 0.7132, 2.40, 0.096, 132, 115, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S3I2) COMPLEX
922, 1d0hA, 0.7132, 2.98, 0.050, 441, 121, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH N-ACETYL- GALACTOSAMINE
923, 1diwA, 0.7131, 2.99, 0.050, 441, 121, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH GALACTOSE
924, 3rmxD, 0.7128, 3.12, 0.074, 406, 122, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
925, 3rmxB, 0.7126, 3.13, 0.083, 407, 121, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
926, 1g82D, 0.7126, 2.47, 0.096, 155, 115, STRUCTURE OF FIBROBLAST GROWTH FACTOR 9
927, 1z0hB, 0.7125, 2.91, 0.049, 438, 123, N-TERMINAL HELIX REORIENTS IN RECOMBINANT C-FRAGMENT OF CLOSTRIDIUM BOTULINUM TYPE B
928, 1af9A, 0.7123, 3.00, 0.050, 441, 121, TETANUS NEUROTOXIN C FRAGMENT
929, 3ud7B, 0.7122, 2.37, 0.105, 127, 114, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI21) COMPLEXES
930, 3rmyD, 0.7121, 2.97, 0.083, 404, 120, CRYSTAL STRUCTURE OF HCR/D W1238A MUTANT
931, 3f1rB, 0.7121, 2.48, 0.096, 157, 115, CRYSTAL STRUCTURE OF FGF20 DIMER
932, 3f1rA, 0.7121, 2.48, 0.096, 157, 115, CRYSTAL STRUCTURE OF FGF20 DIMER
933, 1fv2A, 0.7121, 3.00, 0.050, 451, 121, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
934, 1fv3B, 0.7119, 3.01, 0.050, 451, 121, THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B
935, 1axmD, 0.7119, 2.39, 0.105, 126, 114, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
936, 1blaA, 0.7117, 2.41, 0.095, 155, 116, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
937, 1ytoC, 0.7116, 2.45, 0.113, 141, 115, CRYSTAL STRUCTURE OF GLY19 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
938, 5vidA, 0.7115, 2.94, 0.065, 415, 123, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
939, 4oegA, 0.7106, 2.30, 0.097, 124, 113, CRYSTAL STRUCTURE ANALYSIS OF FGF2-DISACCHARIDE (S9I2) COMPLEX
940, 3zxdC, 0.7106, 2.61, 0.140, 290, 114, WILD-TYPE LYSENIN
941, 1fgaA, 0.7106, 2.33, 0.097, 124, 113, REFINEMENT OF THE STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION AND ANALYSIS OF PRESUMED HEPARIN BINDING SITES BY SELENATE SUBSTITUTION
942, 5n0cA, 0.7105, 2.89, 0.050, 1293, 120, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
943, 4kbbB, 0.7103, 2.87, 0.066, 417, 122, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
944, 1axmB, 0.7103, 2.41, 0.096, 126, 114, HEPARIN-LINKED BIOLOGICALLY-ACTIVE DIMER OF FIBROBLAST GROWTH FACTOR
945, 4kbbA, 0.7100, 2.88, 0.066, 417, 122, STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A
946, 4fgfA, 0.7100, 2.31, 0.097, 124, 113, REFINEMENT OF THE STRUCTURE OF HUMAN BASIC FIBROBLAST GROWTH FACTOR AT 1.6 ANGSTROMS RESOLUTION AND ANALYSIS OF PRESUMED HEPARIN BINDING SITES BY SELENATE SUBSTITUTION
947, 3hbwB, 0.7100, 2.58, 0.148, 149, 115, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
948, 4cjmB, 0.7099, 2.46, 0.104, 128, 115, CRYSTAL STRUCTURE OF HUMAN FGF18
949, 3rmxC, 0.7098, 3.04, 0.083, 403, 120, CRYSTAL STRUCTURE OF HCR/D F1240A MUTANT
950, 3hbwA, 0.7098, 2.58, 0.148, 149, 115, CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTOR 2A (FHF2A) ALSO REFERRED TO AS FIBROBLAST GROWTH FACTOR 13A (FGF13A)
951, 3zxdA, 0.7096, 2.64, 0.140, 293, 114, WILD-TYPE LYSENIN
952, 1qqlA, 0.7096, 2.47, 0.096, 131, 115, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7/1 CHIMERA
953, 4jraB, 0.7093, 2.97, 0.090, 413, 122, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN A RECEPTOR-BINDING DOMAIN IN COMPLEX WITH THE LUMINAL DOMAIN OF SV2C
954, 5n0cB, 0.7087, 2.91, 0.050, 1286, 120, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
955, 3zxdB, 0.7087, 2.50, 0.142, 294, 113, WILD-TYPE LYSENIN
956, 3zxdD, 0.7086, 2.50, 0.142, 289, 113, WILD-TYPE LYSENIN
957, 1k5vB, 0.7084, 2.36, 0.115, 126, 113, HUMAN ACIDIC FIBROBLAST GROWTH FACTOR. 141 AMINO ACID FORM WITH AMINO TERMINAL HIS TAG WITH ASN106 REPLACED BY GLY (N106G).
958, 5ec5S, 0.7081, 2.70, 0.140, 283, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
959, 3zxgA, 0.7081, 2.68, 0.140, 293, 114, LYSENIN SPHINGOMYELIN COMPLEX
960, 1dfcB, 0.7081, 2.46, 0.115, 474, 113, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
961, 3zxgB, 0.7080, 2.67, 0.140, 293, 114, LYSENIN SPHINGOMYELIN COMPLEX
962, 5gaqF, 0.7079, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
963, 4cjmC, 0.7078, 2.48, 0.104, 128, 115, CRYSTAL STRUCTURE OF HUMAN FGF18
964, 3udaA, 0.7078, 2.37, 0.106, 126, 113, CRYSTAL STRUCTURE ANALYSIS OF FGF1-DISACCHARIDE(NI24) COMPLEX
965, 5ec5A, 0.7077, 2.82, 0.139, 290, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
966, 1z4sC, 0.7075, 2.44, 0.114, 140, 114, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
967, 5gaqI, 0.7074, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
968, 5gaqH, 0.7074, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
969, 5gaqG, 0.7074, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
970, 5gaqE, 0.7074, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
971, 5gaqD, 0.7074, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
972, 5gaqC, 0.7074, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
973, 5gaqA, 0.7074, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
974, 5gaqB, 0.7073, 2.68, 0.140, 288, 114, CRYO-EM STRUCTURE OF THE LYSENIN PORE
975, 5ec5L, 0.7073, 2.69, 0.140, 284, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
976, 1q1uA, 0.7073, 2.58, 0.130, 138, 115, CRYSTAL STRUCTURE OF HUMAN FHF1B (FGF12B)
977, 1dfcA, 0.7073, 2.47, 0.115, 475, 113, CRYSTAL STRUCTURE OF HUMAN FASCIN AN ACTIN-CROSSLINKING PROTEIN
978, 5ec5O, 0.7072, 2.82, 0.139, 289, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
979, 1z4sA, 0.7071, 2.43, 0.114, 138, 114, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
980, 5hpzA, 0.7068, 2.90, 0.085, 175, 117, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
981, 5ec5I, 0.7068, 2.70, 0.140, 282, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
982, 5ec5C, 0.7068, 2.81, 0.139, 286, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
983, 5n0bA, 0.7067, 2.93, 0.050, 1280, 120, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GD1A
984, 5ec5J, 0.7067, 2.82, 0.139, 290, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
985, 3zc9A, 0.7067, 2.81, 0.127, 182, 118, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 4.6
986, 4jpzE, 0.7066, 2.60, 0.139, 148, 115, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
987, 3zc8A, 0.7066, 2.83, 0.127, 182, 118, CRYSTAL STRUCTURE OF MURRAYA KOENIGII MIRACULIN-LIKE PROTEIN AT 2.2 A RESOLUTION AT PH 7.0
988, 4cjmD, 0.7065, 2.49, 0.104, 129, 115, CRYSTAL STRUCTURE OF HUMAN FGF18
989, 5ec5H, 0.7064, 2.68, 0.140, 283, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
990, 5ec5P, 0.7063, 2.81, 0.139, 289, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
991, 5ec5E, 0.7062, 2.83, 0.139, 283, 115, CRYSTAL STRUCTURE OF LYSENIN PORE
992, 1z4sD, 0.7060, 2.44, 0.123, 137, 114, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
993, 2dreD, 0.7059, 2.90, 0.084, 177, 119, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
994, 5ec5M, 0.7058, 2.68, 0.140, 289, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
995, 5ec5D, 0.7058, 2.72, 0.140, 285, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
996, 1z4sB, 0.7058, 2.47, 0.104, 140, 115, CRYSTAL STRUCTURE OF GLY19 AND GLU60 DELETION MUTANT OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR
997, 5x9zA, 0.7057, 2.98, 0.092, 1710, 120, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
998, 5ec5K, 0.7057, 2.70, 0.140, 290, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
999, 5ec5G, 0.7057, 2.71, 0.140, 290, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1000, 5ec5B, 0.7055, 2.70, 0.140, 284, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1001, 5hpzB, 0.7050, 2.90, 0.085, 175, 117, TYPE II WATER SOLUBLE CHL BINDING PROTEINS
1002, 5ec5R, 0.7048, 2.70, 0.140, 283, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1003, 5ec5N, 0.7048, 2.56, 0.142, 289, 113, CRYSTAL STRUCTURE OF LYSENIN PORE
1004, 4dckC, 0.7045, 2.64, 0.139, 148, 115, CRYSTAL STRUCTURE OF THE C-TERMINUS OF VOLTAGE-GATED SODIUM CHANNEL IN COMPLEX WITH FGF13 AND CAM
1005, 2dreC, 0.7045, 2.90, 0.084, 177, 119, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
1006, 4jpzA, 0.7043, 2.62, 0.139, 148, 115, VOLTAGE-GATED SODIUM CHANNEL 1.2 C-TERMINAL DOMAIN IN COMPLEX WITH FGF13U AND CA2+/CALMODULIN
1007, 5ec5F, 0.7042, 2.72, 0.140, 283, 114, CRYSTAL STRUCTURE OF LYSENIN PORE
1008, 3s8kA, 0.7042, 2.71, 0.061, 183, 115, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
1009, 3iirA, 0.7042, 2.90, 0.119, 190, 118, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
1010, 1qqkA, 0.7038, 2.51, 0.070, 129, 114, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7 (KERATINOCYTE GROWTH FACTOR)
1011, 3iirB, 0.7036, 2.90, 0.119, 190, 118, CRYSTAL STRUCTURE OF MIRACULIN LIKE PROTEIN FROM SEEDS OF MURRAYA KOENIGII
1012, 1nunA, 0.7031, 2.60, 0.078, 139, 115, CRYSTAL STRUCTURE ANALYSIS OF THE FGF10-FGFR2B COMPLEX
1013, 3pmeA, 0.7030, 3.23, 0.082, 415, 122, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN C/D MOSAIC SEROTYPE
1014, 4f83A, 0.7025, 3.24, 0.074, 413, 122, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN MOSAIC SEROTYPE C/D WITH A TETRAETHYLENE GLYCOL MOLECULE BOUND ON THE HCN SUB-DOMAIN AND A SULFATE ION AT THE PUTATIVE ACTIVE SITE
1015, 5uc6A, 0.7022, 2.65, 0.061, 151, 115, STRUCTURAL INSIGHTS INTO IL-1 ALPHA RECOGNITION BY A NAPHTHYL-MODIFIED APTAMER THAT MIMICS IL-1RI DOMAIN III
1016, 1bldA, 0.7015, 2.51, 0.086, 155, 116, BASIC FIBROBLAST GROWTH FACTOR (FGF-2) MUTANT WITH CYS 78 REPLACED BY SER AND CYS 96 REPLACED BY SER NMR
1017, 5yczB, 0.7013, 2.71, 0.078, 172, 116, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
1018, 3javC, 0.7003, 2.89, 0.025, 2327, 121, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1019, 3javB, 0.7003, 2.89, 0.025, 2327, 121, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1020, 3javA, 0.7003, 2.89, 0.025, 2327, 121, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1021, 5v38A, 0.7002, 2.95, 0.099, 418, 121, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN TYPE HA
1022, 3javD, 0.7002, 2.89, 0.025, 2327, 121, STRUCTURE OF FULL-LENGTH IP3R1 CHANNEL IN THE APO-STATE DETERMINED BY SINGLE PARTICLE CRYO-EM
1023, 1ijtA, 0.7002, 2.47, 0.114, 128, 114, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 4 (FGF4)
1024, 2kh2A, 0.6996, 2.80, 0.069, 153, 116, SOLUTION STRUCTURE OF A SCFV-IL-1B COMPLEX
1025, 5yczA, 0.6995, 2.91, 0.076, 178, 118, CRYSTAL STRUCTURE OF ALOCASIN; PROTEASE INHIBITOR FROM GIANT TARO (ARUM MACRORRHIZON) 
1026, 3s8kB, 0.6986, 2.76, 0.061, 182, 115, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 1.7A RESOLUTION
1027, 2dreB, 0.6985, 2.80, 0.085, 173, 117, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
1028, 3zx7A, 0.6982, 2.64, 0.143, 290, 112, COMPLEX OF LYSENIN WITH PHOSPHOCHOLINE
1029, 3i2aA, 0.6982, 2.81, 0.043, 180, 117, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
1030, 2yugA, 0.6979, 2.60, 0.105, 155, 114, SOLUTION STRUCTURE OF MOUSE FRG1 PROTEIN
1031, 3s8jB, 0.6975, 2.76, 0.061, 181, 115, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
1032, 5tpbA, 0.6974, 2.77, 0.085, 411, 117, BINDING DOMAIN OF BONT/A COMPLEXED WITH GANGLIOSIDE VARIANT
1033, 4jq0A, 0.6966, 2.67, 0.113, 141, 115, VOLTAGE-GATED SODIUM CHANNEL 1.5 C-TERMINAL DOMAIN IN COMPLEX WITH FGF12B AND CA2+/CALMODULIN
1034, 3azvA, 0.6963, 2.71, 0.068, 405, 117, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
1035, 3qr5B, 0.6951, 2.06, 0.093, 154, 107, STRUCTURE OF THE FIRST DOMAIN OF A CARDIAC RYANODINE RECEPTOR MUTANT WITH EXON 3 DELETED
1036, 3mppG, 0.6949, 3.02, 0.083, 403, 121, BOTULINUM NEUROTOXIN TYPE G RECEPTOR BINDING DOMAIN
1037, 3azvB, 0.6949, 2.79, 0.059, 405, 118, CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN
1038, 4an6B, 0.6933, 2.97, 0.078, 171, 116, KUNTIZ TYPE TRYPSIN INHIBITOR WITH FACTOR XA INHIBITORY ACTIVITY
1039, 1qqkB, 0.6933, 2.44, 0.071, 125, 112, THE CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 7 (KERATINOCYTE GROWTH FACTOR)
1040, 3h6rB, 0.6928, 2.77, 0.116, 152, 112, CLITOCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
1041, 2l5xD, 0.6928, 2.74, 0.078, 151, 116, SOLUTION STRUCTURE OF IL1A-S100A13 COMPLEX
1042, 3i29B, 0.6921, 2.87, 0.051, 175, 117, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN MUTANT TRYPSIN INHIBITOR WITH BOVINE TRYPSIN
1043, 2bebB, 0.6920, 2.84, 0.051, 173, 117, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
1044, 5x9zB, 0.6919, 2.91, 0.101, 1708, 119, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR LARGE CYTOSOLIC DOMAIN
1045, 3s8jA, 0.6912, 2.83, 0.061, 182, 115, CRYSTAL STRUCTURE OF A PAPAYA LATEX SERINE PROTEASE INHIBITOR (PPI) AT 2.6A RESOLUTION
1046, 2l5xA, 0.6908, 2.76, 0.078, 151, 116, SOLUTION STRUCTURE OF IL1A-S100A13 COMPLEX
1047, 5bowA, 0.6906, 2.79, 0.103, 151, 116, CRYSTAL STRUCTURE OF IL-38
1048, 3rsjB, 0.6904, 2.63, 0.106, 402, 113, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1049, 2ilaA, 0.6900, 2.69, 0.061, 145, 114, STRUCTURE OF INTERLEUKIN 1ALPHA AT 2.7-ANGSTROMS RESOLUTION
1050, 5wvxA, 0.6899, 2.72, 0.061, 157, 114, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
1051, 5vi4D, 0.6884, 2.37, 0.100, 146, 110, IL-33/ST2/IL-1RACP TERNARY COMPLEX STRUCTURE
1052, 41biA, 0.6874, 3.19, 0.059, 150, 119, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 8 REPLACED BY ALA (C8A)
1053, 3veqA, 0.6874, 2.88, 0.051, 175, 117, A BINARY COMPLEX BETWWEN BOVINE PANCREATIC TRYPSIN AND A ENGINEERED MUTANT TRYPSIN INHIBITOR
1054, 3rsjC, 0.6871, 2.71, 0.105, 402, 114, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1055, 6i1bA, 0.6868, 3.09, 0.076, 153, 118, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
1056, 3ltqA, 0.6867, 2.94, 0.060, 168, 116, STRUCTURE OF INTERLEUKIN 1B SOLVED BY SAD USING AN INSERTED LANTHANIDE BINDING TAG
1057, 31biA, 0.6866, 3.19, 0.067, 149, 119, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY SER) (C71S)
1058, 1iobA, 0.6864, 3.19, 0.067, 153, 119, INTERLEUKIN-1 BETA FROM JOINT X-RAY AND NMR REFINEMENT
1059, 4ha2A, 0.6862, 2.96, 0.051, 174, 117, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
1060, 1s0lA, 0.6862, 3.18, 0.067, 153, 119, INTERLEUKIN 1 BETA MUTANT F42W
1061, 5vi4A, 0.6860, 2.58, 0.089, 146, 112, IL-33/ST2/IL-1RACP TERNARY COMPLEX STRUCTURE
1062, 1hceA, 0.6860, 2.47, 0.090, 118, 111, STRUCTURE OF HISACTOPHILIN IS SIMILAR TO INTERLEUKIN-1 BETA AND FIBROBLAST GROWTH FACTOR
1063, 21biA, 0.6859, 3.20, 0.076, 151, 119, INTERLEUKIN-1 BETA (IL-1 BETA) (MUTANT WITH CYS 71 REPLACED BY ALA) (C71A)
1064, 1tp0A, 0.6856, 3.24, 0.067, 153, 119, TRIPLE MUTATION IN INTERLEUKIN 1 BETA CAVITY:REPLACEMENT OF PHENYLALANINES WITH TRYPTOPHAN.
1065, 2et2A, 0.6854, 2.91, 0.051, 175, 117, CRYSTAL STRUCTURE OF AN ASN TO ALA MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
1066, 3h6rA, 0.6853, 2.80, 0.108, 152, 111, CLITOCYPIN A BETA-TREFOIL CYSTEINE PROTEASE INHIBITOR
1067, 2i1bA, 0.6853, 3.20, 0.059, 153, 119, CRYSTALLOGRAPHIC REFINEMENT OF INTERLEUKIN-1 BETA AT 2.0 ANGSTROMS RESOLUTION
1068, 1tweA, 0.6853, 3.22, 0.059, 153, 119, INTERLEUKIN 1 BETA MUTANT F101Y
1069, 1i1bA, 0.6853, 3.20, 0.059, 151, 119, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN INTERLEUKIN-1BETA AT 2.0 ANGSTROMS RESOLUTION
1070, 5i1bA, 0.6852, 3.18, 0.059, 151, 119, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
1071, 4ha2B, 0.6852, 2.97, 0.051, 173, 117, CRYSTAL STRUCTURE OFA PHENYL ALANINE 91 MUTANT OF WCI
1072, 1t4qA, 0.6852, 3.24, 0.067, 153, 119, INTERLEUKIN 1 BETA F101W
1073, 4i1bA, 0.6850, 3.21, 0.067, 151, 119, FUNCTIONAL IMPLICATIONS OF INTERLEUKIN-1BETA BASED ON THE THREE-DIMENSIONAL STRUCTURE
1074, 4tlpA, 0.6848, 2.99, 0.051, 175, 117, CRYSTAL STRUCTURE OF A ALANINE91 MUTANT OF WCI
1075, 1twmA, 0.6848, 3.22, 0.050, 153, 119, INTERLEUKIN-1 BETA MUTANT F146Y
1076, 1tooA, 0.6848, 3.23, 0.050, 153, 119, INTERLEUKIN 1B MUTANT F146W
1077, 2wbcA, 0.6846, 2.91, 0.051, 183, 117, REFINED CRYSTAL STRUCTURE (2.3 ANGSTROM) OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR AND LOCATION OF ITS SECOND REACTIVE SITE
1078, 1wbcA, 0.6846, 2.93, 0.051, 183, 117, CRYSTALLIZATION AND PRELIMINARY X-RAY STUDIES OF PSOPHOCARPIN B1 A CHYMOTRYPSIN INHIBITOR FROM WINGED BEAN SEEDS
1079, 3h6sG, 0.6842, 2.68, 0.109, 150, 110, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1080, 7i1bA, 0.6840, 3.20, 0.067, 153, 119, HIGH-RESOLUTION THREE-DIMENSIONAL STRUCTURE OF INTERLEUKIN- 1 BETA IN SOLUTION BY THREE-AND FOUR-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
1081, 2p39A, 0.6840, 2.57, 0.073, 142, 110, CRYSTAL STRUCTURE OF HUMAN FGF23
1082, 1xg6A, 0.6838, 2.98, 0.051, 179, 117, THE CRYSTAL STRUCTURE OF THE P1 MUTANT (LEU TO ARG)OF A WINGED BEAN CHYMOTRYPSIN INHIBITOR(KUNITZ)SOLVED AT 2.15A RESOLUTION
1083, 3qr5A, 0.6837, 2.00, 0.096, 151, 104, STRUCTURE OF THE FIRST DOMAIN OF A CARDIAC RYANODINE RECEPTOR MUTANT WITH EXON 3 DELETED
1084, 2bebA, 0.6835, 2.96, 0.051, 170, 117, X-RAY STRUCTURE OF ASN TO THR MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR
1085, 9ilbA, 0.6833, 3.15, 0.050, 153, 119, HUMAN INTERLEUKIN-1 BETA
1086, 3ffzA, 0.6832, 2.64, 0.150, 1246, 113, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
1087, 2beaB, 0.6827, 2.93, 0.051, 170, 117, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
1088, 4depA, 0.6824, 2.99, 0.068, 151, 117, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
1089, 1eylA, 0.6823, 2.95, 0.051, 179, 117, STRUCTURE OF A RECOMBINANT WINGED BEAN CHYMOTRYPSIN INHIBITOR
1090, 1fmzA, 0.6820, 2.95, 0.051, 179, 117, CRYSTAL STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14K.
1091, 4depD, 0.6818, 3.00, 0.068, 152, 117, STRUCTURE OF THE IL-1B SIGNALING COMPLEX
1092, 3i2aB, 0.6817, 3.00, 0.043, 180, 117, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR PROTEIN STI(L)- WCI(S)
1093, 2nvhA, 0.6817, 3.21, 0.050, 152, 119, DETERMINATION OF SOLVENT CONTENT IN CAVITIES IN INTERLEUKIN- 1 USING EXPERIMENTALLY-PHASED ELECTRON DENSITY
1094, 2esuA, 0.6813, 2.94, 0.051, 173, 117, CRYSTAL STRUCTURE OF ASN TO GLN MUTANT OF WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
1095, 1fmmS, 0.6813, 2.74, 0.138, 132, 116, SOLUTION STRUCTURE OF NFGF-1
1096, 3ffzB, 0.6811, 2.77, 0.149, 1238, 114, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
1097, 1r8nA, 0.6811, 2.99, 0.078, 185, 116, THE CRYSTAL STRUCTURE OF THE KUNITZ (STI) TYPE INHIBITOR FROM SEEDS OF DELONIX REGIA
1098, 4g6jA, 0.6808, 2.98, 0.052, 149, 116, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
1099, 2qyiD, 0.6807, 3.07, 0.051, 175, 118, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
1100, 4wbcA, 0.6805, 2.97, 0.051, 179, 117, 2.13 A STRUCTURE OF A KUNITZ-TYPE WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN
1101, 5w21B, 0.6802, 2.56, 0.073, 182, 110, CRYSTAL STRUCTURE OF A 1:1:1 FGF23-FGFR1C-AKLOTHO TERNARY COMPLEX
1102, 2mibA, 0.6799, 3.04, 0.069, 149, 116, THE STRUCTURE OF MURINE INTERLEUKIN-1 BETA AT 2.8 ANGSTROMS RESOLUTION
1103, 2beaA, 0.6796, 3.01, 0.051, 170, 117, CRYSTAL STRUCTURE OF ASN14 TO GLY MUTANT OF WCI
1104, 3fuqA, 0.6793, 2.63, 0.108, 399, 111, GLYCOSYLATED SV2 AND GANGLIOSIDES AS DUAL RECEPTORS FOR BOTULINUM NEUROTOXIN SEROTYPE F
1105, 1fn0A, 0.6793, 2.97, 0.051, 177, 117, STRUCTURE OF A MUTANT WINGED BEAN CHYMOTRYPSIN INHIBITOR PROTEIN N14D.
1106, 3o4oA, 0.6791, 3.26, 0.059, 152, 119, CRYSTAL STRUCTURE OF AN INTERLEUKIN-1 RECEPTOR COMPLEX
1107, 3i2xB, 0.6787, 3.01, 0.043, 181, 117, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
1108, 2qyiB, 0.6787, 2.97, 0.051, 175, 117, CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
1109, 2kllA, 0.6785, 2.82, 0.154, 161, 117, SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-33
1110, 4g6mA, 0.6784, 3.06, 0.060, 150, 117, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
1111, 3h6sE, 0.6784, 2.76, 0.109, 150, 110, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1112, 5wvxB, 0.6783, 2.61, 0.063, 153, 111, CRYSTAL STRUCTURE OF BIFUNCTIONAL KUNITZ TYPE TRYPSIN /AMYLASE INHIBITOR (AMTIN) FROM THE TUBERS OF ALOCASIA MACRORRHIZA 
1113, 3h6sH, 0.6778, 2.75, 0.100, 150, 110, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1114, 5xa0A, 0.6776, 3.17, 0.092, 1252, 120, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
1115, 4zktC, 0.6776, 2.68, 0.142, 1235, 113, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1116, 4zktE, 0.6771, 2.68, 0.142, 1235, 113, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1117, 4zktA, 0.6771, 2.69, 0.142, 1235, 113, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
1118, 3pokA, 0.6770, 3.23, 0.050, 159, 120, INTERLEUKIN-1-BETA LBT L3 MUTANT
1119, 3nj5A, 0.6770, 3.23, 0.067, 152, 119, CRYSTAL STRUCTURE OF CHICKEN IL-1 HYDROPHOBIC CAVITY MUTANT 157
1120, 8i1bA, 0.6768, 3.09, 0.068, 146, 117, A COMPARISON OF THE HIGH RESOLUTION STRUCTURES OF HUMAN AND MURINE INTERLEUKIN-1B
1121, 4x3aA, 0.6761, 2.97, 0.060, 147, 116, GALLUS INTERLEUKIN-1 BETA MUTANT - R140A
1122, 4h9wA, 0.6761, 3.00, 0.051, 177, 117, CRYSTAL STRUCTURE OF A METHIONINE MUTANT OF WCI
1123, 3qydC, 0.6760, 3.02, 0.043, 177, 117, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
1124, 1itbA, 0.6757, 3.06, 0.060, 153, 117, TYPE-1 INTERLEUKIN-1 RECEPTOR COMPLEXED WITH INTERLEUKIN-1 BETA
1125, 3h6sF, 0.6750, 2.71, 0.110, 150, 109, STRUCTURE OF CLITOCYPIN - CATHEPSIN V COMPLEX
1126, 1hibA, 0.6750, 2.99, 0.069, 150, 116, THE STRUCTURE OF AN INTERLEUKIN-1 BETA MUTANT WITH REDUCED BIOACTIVITY SHOWS MULTIPLE SUBTLE CHANGES IN CONFORMATION THAT AFFECT PROTEIN- PROTEIN RECOGNITION
1127, 4gafA, 0.6743, 3.24, 0.076, 152, 118, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA BOUND TO HUMAN INTERLEUKIN-1 RECEPTOR TYPE 1
1128, 4x39A, 0.6738, 3.19, 0.059, 154, 118, GALLUS INTERLEUKIN-1 BETA MUTANT - T117A
1129, 4x37A, 0.6737, 3.06, 0.060, 159, 117, GALLUS INTERLEUKIN-1 MUTANT - E118K
1130, 3qydB, 0.6736, 3.03, 0.052, 177, 116, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
1131, 2dreA, 0.6736, 2.98, 0.113, 172, 115, CRYSTAL STRUCTURE OF WATER-SOLUBLE CHLOROPHYLL PROTEIN FROM LEPIDIUM VIRGINICUM AT 2.00 ANGSTROM RESOLUTION
1132, 3i2xA, 0.6735, 3.03, 0.043, 178, 117, CRYSTAL STRUCTURE OF A CHIMERIC TRYPSIN INHIBITOR HAVING REACTIVE SITE LOOP OF ETI ON THE SCAFFOLD OF WCI
1133, 3qydA, 0.6734, 3.08, 0.043, 177, 117, CRYSTAL STRUCTURE OF A RECOMBINANT CHIMERIC TRYPSIN INHIBITOR
1134, 4an6A, 0.6732, 3.01, 0.080, 172, 113, KUNTIZ TYPE TRYPSIN INHIBITOR WITH FACTOR XA INHIBITORY ACTIVITY
1135, 2wryA, 0.6728, 3.07, 0.060, 154, 117, CRYSTAL STRUCTURE OF CHICKEN CYTOKINE INTERLEUKIN 1 BETA
1136, 4x38A, 0.6727, 3.01, 0.060, 149, 116, GALLUS INTERLEUKIN-1 BETA MUTANT - E118A
1137, 1tieA, 0.6722, 3.01, 0.043, 166, 115, CRYSTAL STRUCTURE OF A KUNITZ-TYPE TRYPSIN INHIBITOR FROM ERYTHRINA CAFFRA SEEDS
1138, 4gaiA, 0.6720, 3.30, 0.068, 152, 118, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
1139, 3snvA, 0.6705, 2.12, 0.106, 125, 104, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1140, 4p0kA, 0.6699, 2.92, 0.105, 144, 114, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA
1141, 2ki6E, 0.6699, 2.77, 0.114, 133, 114, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
1142, 2ki4D, 0.6699, 2.77, 0.114, 133, 114, FGF1-S100A13 COMPLEX STRUCTURE: KEY COMPONENT IN NON-CLASSICAL PATH WAY OF FGF1
1143, 4p0lA, 0.6698, 2.92, 0.105, 143, 114, CRYSTAL STRUCTURE OF DOUBLE LOOP-SWAPPED INTERLEUKIN-36RA WITH ADDITIONAL POINT MUTATIONS
1144, 5hn1A, 0.6697, 3.23, 0.102, 157, 118, CRYSTAL STRUCTURE OF INTERLEUKIN-37
1145, 3snvB, 0.6691, 2.13, 0.106, 124, 104, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #1: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1146, 5xozA, 0.6689, 3.02, 0.062, 178, 113, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
1147, 5mvzV, 0.6689, 3.07, 0.061, 144, 115, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
1148, 2kkiA, 0.6684, 3.03, 0.078, 151, 116, SOLUTION STRUCTURE OF HUMAN INTERLEUKIN 1A
1149, 5hn1B, 0.6683, 3.09, 0.103, 149, 116, CRYSTAL STRUCTURE OF INTERLEUKIN-37
1150, 2ki6B, 0.6682, 2.79, 0.114, 133, 114, THE FGF1-S100A13-C2A HETERO-HEXAMERIC COMPLEX STRUCTURE: A COMPONENT IN THE NON-CLASSICAL PATHWAY FOR FGF1 SECRETION
1151, 2ki4A, 0.6682, 2.79, 0.114, 133, 114, FGF1-S100A13 COMPLEX STRUCTURE: KEY COMPONENT IN NON-CLASSICAL PATH WAY OF FGF1
1152, 4p0jB, 0.6677, 2.98, 0.104, 147, 115, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
1153, 2k4aB, 0.6662, 2.81, 0.114, 133, 114, FGF-1-C2A BINARY COMPLEX STRUCTURE: A KEY COMPONENT IN THE FIBROBLAST GROWTHFACTOR NON-CLASSICAL PATHWAY
1154, 5xozB, 0.6659, 3.14, 0.061, 179, 115, CRYSTAL STRUCTURE OF A KUNITZ TYPE TRYPSIN INHIBITOR FROM CICER ARIETINUML 
1155, 5xa0B, 0.6641, 3.25, 0.101, 1252, 119, CRYSTAL STRUCTURE OF INOSITOL 145-TRISPHOSPHATE RECEPTOR CYTOSOLIC DOMAIN
1156, 1l2hA, 0.6636, 3.20, 0.043, 144, 116, CRYSTAL STRUCTURE OF INTERLEUKIN 1-BETA F42W/W120F MUTANT
1157, 4p0jA, 0.6633, 3.00, 0.113, 147, 115, CRYSTAL STRUCTURE OF LOOP-SWAPPED INTERLEUKIN-36RA
1158, 4izeA, 0.6614, 3.19, 0.096, 151, 115, CRYSTAL STRUCTURE OF IL-36GAMMA
1159, 2k8rA, 0.6611, 2.91, 0.114, 133, 114, SOLUTION STRUCTURE OF HUMAN ACIDIC FIBROBLAST GROWTH FACTOR IN COMPLEX WITH ANTI-ANGIOGENIC DRUG INOSITOL HEXAPHOSPHATE (IP6)
1160, 5bvpI, 0.6609, 3.23, 0.052, 149, 116, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
1161, 4kc3A, 0.6586, 2.89, 0.159, 134, 113, CYTOKINE/RECEPTOR BINARY COMPLEX
1162, 4an7B, 0.6573, 3.22, 0.079, 156, 114, KUNITZ TYPE TRYPSIN INHIBITOR COMPLEX WITH PORCINE TRYPSIN
1163, 2k43A, 0.6558, 2.97, 0.106, 133, 113, ACIDIC FIBROBLAST GROWTH FACTOR SOLUTION STRUCTURE IN THE FGF-1-C2A BINARY COMPLEX: KEY COMPONENT IN THE FIBROBLAST GROWTHFACTOR NON-CLASSICAL PATHWAY
1164, 2p23A, 0.6546, 3.20, 0.081, 136, 111, CRYSTAL STRUCTURE OF HUMAN FGF19
1165, 2p23B, 0.6545, 3.20, 0.081, 136, 111, CRYSTAL STRUCTURE OF HUMAN FGF19
1166, 4gaiB, 0.6540, 3.19, 0.070, 140, 114, CRYSTAL STRUCTURE OF EBI-005 A CHIMERA OF HUMAN IL-1BETA AND IL-1RA
1167, 3p6jA, 0.6539, 2.12, 0.099, 125, 101, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #3: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1168, 1md6A, 0.6522, 3.31, 0.095, 154, 116, HIGH RESOLUTION CRYSTAL STRUCTURE OF MURINE IL-1F5 REVEALS UNIQUE LOOP CONFORMATION FOR SPECIFICITY
1169, 1hcdA, 0.6490, 2.95, 0.098, 118, 112, STRUCTURE OF HISACTOPHILIN IS SIMILAR TO INTERLEUKIN-1 BETA AND FIBROBLAST GROWTH FACTOR
1170, 1rmlA, 0.6383, 3.12, 0.114, 131, 114, NMR STUDY OF ACID FIBROBLAST GROWTH FACTOR BOUND TO 136- NAPHTHALENE TRISULPHONATE 26 STRUCTURES
1171, 5mvzU, 0.6370, 2.88, 0.037, 136, 107, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
1172, 1pwaA, 0.6340, 2.45, 0.079, 123, 101, CRYSTAL STRUCTURE OF FIBROBLAST GROWTH FACTOR 19
1173, 1dzdA, 0.6275, 3.10, 0.099, 127, 111, HIGH RESOLUTION STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR (27-154) 24 NMR STRUCTURES
1174, 3p6iA, 0.6196, 2.20, 0.062, 127, 97, CRYSTAL STRUCTURE OF SYMFOIL-4T PERMUTATION #2: DE NOVO DESIGNED BETA- TREFOIL ARCHITECTURE WITH SYMMETRIC PRIMARY STRUCTURE
1175, 5fv9D, 0.5335, 2.05, 0.122, 443, 82, CRYSTAL STRUCTURE OF GALNAC-T2 IN COMPLEX WITH COMPOUND 16D
1176, 2vu9A, 0.5235, 3.22, 0.067, 425, 89, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B
1177, 5jlvA, 0.5211, 3.14, 0.068, 425, 88, RECEPTOR BINDING DOMAIN OF BOTULINUM NEUROTOXIN A IN COMPLEX WITH HUMAN GLYCOSYLATED SV2C
1178, 3r4uB, 0.5131, 2.99, 0.093, 422, 86, CELL ENTRY OF BOTULINUM NEUROTOXIN TYPE C IS DEPENDENT UPON INTERACTION WITH TWO GANGLIOSIDE MOLECULES
1179, 3v0bA, 0.5124, 3.29, 0.068, 1280, 88, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
1180, 3v0aA, 0.5124, 3.29, 0.068, 1280, 88, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
1181, 3rsjA, 0.5115, 3.07, 0.092, 406, 87, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1182, 3rsjD, 0.5092, 3.04, 0.093, 404, 86, STRUCTURE OF HCRF IN COMPLEX WITH GANGLIOSIDE GD1A
1183, 5mk6A, 0.5086, 3.18, 0.070, 421, 86, CRYSTAL STRUCTURE OF THE RECEPTOR-BINDING DOMAIN OF BOTULINUM NEUROTOXIN A1 (CRYSTAL FORM 1)
1184, 6f0pA, 0.5084, 3.21, 0.093, 418, 86, BOTULINUM NEUROTOXIN A4 HC DOMAIN
1185, 5vmrB, 0.5084, 3.07, 0.070, 419, 86, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
1186, 5vmrA, 0.5081, 3.06, 0.070, 421, 86, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.2110.4
1187, 1s0fA, 0.5081, 3.11, 0.070, 1276, 86, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0
1188, 5l21A, 0.5080, 3.30, 0.069, 425, 87, CRYSTAL STRUCTURE OF BONT/A RECEPTOR BINDING DOMAIN IN COMPLEX WITH VHH C2
1189, 1g9aA, 0.5076, 3.05, 0.070, 1287, 86, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3)
1190, 5vidC, 0.5075, 3.05, 0.070, 426, 86, RECEPTOR BINDING DOMAIN OF BONT/B IN COMPLEX WITH MINI-PROTEIN BINDER BOT.0671.2
1191, 1s0gA, 0.5073, 3.06, 0.070, 1288, 86, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM
1192, 2np0A, 0.5071, 3.04, 0.070, 1289, 86, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN
